{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "735c79c3-93f0-4eac-a40a-7a9c8043a1ed",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "OPENAI_API_KEY:  ········\n"
     ]
    }
   ],
   "source": [
    "import os, getpass\n",
    "\n",
    "def _set_env(var: str):\n",
    "    if not os.environ.get(var):\n",
    "        os.environ[var] = getpass.getpass(f\"{var}: \")\n",
    "\n",
    "_set_env(\"OPENAI_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "789b31dd-a34b-48bc-8009-2af26b9d8803",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import ChatOpenAI\n",
    "llm = ChatOpenAI(model=\"gpt-5\", temperature=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "3696e0bc-02a8-42f7-b293-f543745fd8d7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "LANGSMITH_API_KEY:  ········\n"
     ]
    }
   ],
   "source": [
    "_set_env(\"LANGSMITH_API_KEY\")\n",
    "os.environ[\"LANGSMITH_TRACING\"] = \"true\"\n",
    "os.environ[\"LANGSMITH_PROJECT\"] = \"langchain-academy\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "c02b37ca-37ee-4937-a83f-28b480ef09bd",
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List\n",
    "from typing_extensions import TypedDict\n",
    "from pydantic import BaseModel, Field\n",
    "\n",
    "class Doctor(BaseModel):\n",
    "    name: str = Field(\n",
    "        description=\"Name of the doctor.\"\n",
    "    )\n",
    "    qualifications: str = Field(\n",
    "        description=\"Qualifications of the doctor\",\n",
    "    )\n",
    "    specialization: str = Field(\n",
    "        description=\"Specialization of the dcotor i.e., cardiologist, dermatologist, orthopedist, etc.\",\n",
    "    )\n",
    "    experience: int = Field(\n",
    "        description=\"Number of years of work experience of the doctor\"\n",
    "    )\n",
    "    description: str = Field(\n",
    "        description=\"Description of the doctor's place of work, achievements, etc.\",\n",
    "    )\n",
    "    @property\n",
    "    def persona(self) -> str:\n",
    "        return f\"Name: {self.name}\\nQualifications: {self.qualifications}\\nSpecialization: {self.specialization}\\nExperience: {self.experience}\\nDescription: {self.description}\\n\"\n",
    "\n",
    "class Perspectives(BaseModel):\n",
    "    doctors: List[Doctor] = Field(\n",
    "        description=\"Comprehensive list of doctors with their specializations, place of work and qualifications.\",\n",
    "    )\n",
    "\n",
    "class GenerateDoctorsState(TypedDict):\n",
    "    symptom: str \n",
    "    max_doctors: int \n",
    "    human_feedback: str \n",
    "    doctors: List[Doctor]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "38d791e7-f23e-40ac-80b8-4bac7a4cc934",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from IPython.display import Image, display\n",
    "from langgraph.graph import START, END, StateGraph\n",
    "from langgraph.checkpoint.memory import MemorySaver\n",
    "from langchain_core.messages import AIMessage, HumanMessage, SystemMessage\n",
    "\n",
    "doctor_instructions=\"\"\"You are tasked with creating a set of Doctors. Follow these instructions carefully:\n",
    "\n",
    "1. First, take a look at the symptom: {symptom}\n",
    "        \n",
    "2. Examine any feedback that has been optionally provided to guide creation of the doctor personas: \n",
    "        \n",
    "{human_feedback}\n",
    "    \n",
    "3. Determine the most suitable specialists who can diagnose the symptom {symptom}.\n",
    "                    \n",
    "4. Pick the top {max_doctors} specialists most suited for the symptom {symptom}.\n",
    "\n",
    "5. Assign one doctor for each specialization.\"\"\"\n",
    "\n",
    "def create_doctors(state: GenerateDoctorsState):\n",
    "    \n",
    "    \"\"\" Create doctors \"\"\"\n",
    "    \n",
    "    symptom=state['symptom']\n",
    "    max_doctors=state['max_doctors']\n",
    "    human_feedback=state.get('human_feedback', '')\n",
    "        \n",
    "    structured_llm = llm.with_structured_output(Perspectives)\n",
    "\n",
    "    system_message = doctor_instructions.format(symptom=symptom,\n",
    "                                                            human_feedback=human_feedback, \n",
    "                                                            max_doctors=max_doctors)\n",
    " \n",
    "    doctors = structured_llm.invoke([SystemMessage(content=system_message)]+[HumanMessage(content=\"Generate the list of doctors.\")])\n",
    "\n",
    "\n",
    "    return {\"doctors\": doctors.doctors}\n",
    "\n",
    "def human_feedback(state: GenerateDoctorsState):\n",
    "    \"\"\" No-op node that should be interrupted on \"\"\"\n",
    "    pass\n",
    "\n",
    "\n",
    "\n",
    "def should_continue(state):\n",
    "    messages = state.get(\"messages\", [])\n",
    "    if not messages:\n",
    "        # No messages yet, decide default behavior\n",
    "        return END  # or \"create_doctors\" if you want to loop\n",
    "    last_message = messages[-1].get(\"content\", \"\").lower()\n",
    "    if \"thank you\" in last_message:\n",
    "        return END\n",
    "    elif len(messages) >= state.get(\"max_num_turns\", 15):\n",
    "        return END\n",
    "    else:\n",
    "        return \"create_doctors\"\n",
    " \n",
    "builder = StateGraph(GenerateDoctorsState)\n",
    "builder.add_node(\"create_doctors\", create_doctors)\n",
    "builder.add_node(\"human_feedback\", human_feedback)\n",
    "builder.add_edge(START, \"create_doctors\")\n",
    "builder.add_edge(\"create_doctors\", \"human_feedback\")\n",
    "builder.add_conditional_edges(\"human_feedback\", should_continue, [\"create_doctors\", END])\n",
    "\n",
    "memory = MemorySaver()\n",
    "graph = builder.compile(interrupt_before=['human_feedback'], checkpointer=memory)\n",
    "\n",
    "display(Image(graph.get_graph(xray=1).draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "e034fe84-cd77-465f-b18e-960a9e471e07",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Dr. Aisha Rahman\n",
      "Experience(in years): 14\n",
      "Qualification: MD, FCCP\n",
      "Specialization: Pulmonologist\n",
      "Description: Consultant Pulmonologist at City Respiratory & Sleep Center. Focuses on pleuritic chest pain, pneumonia, pulmonary embolism workups, and interventional bronchoscopy. Leads a multidisciplinary lung clinic and has authored guidelines on outpatient evaluation of pleuritic chest pain.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Michael Chen\n",
      "Experience(in years): 12\n",
      "Qualification: MD, FACEP\n",
      "Specialization: Emergency Medicine Physician\n",
      "Description: Attending physician in the Emergency Department at Metropolitan General Hospital. Expert in rapid assessment of acute chest and lung pain, including pneumothorax, pulmonary embolism, rib fractures, and pneumonia. Trained in point-of-care ultrasound and advanced cardiac life support protocols.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Sofia Alvarez\n",
      "Experience(in years): 16\n",
      "Qualification: MD, FACC\n",
      "Specialization: Cardiologist\n",
      "Description: Consultant Cardiologist at Heart & Vascular Institute. Specializes in differentiating cardiac causes of chest pain from pulmonary etiologies, including ischemic heart disease and pericarditis. Oversees a chest pain unit and integrates ECG, echocardiography, and CT angiography into diagnostic pathways.\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "# Creating a list of doctors\n",
    "max_doctors = 3 \n",
    "symptom = \"I am having a pain in my lungs\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"1\"}}\n",
    "doctors=()\n",
    "for event in graph.stream({\"symptom\":symptom,\"max_doctors\":max_doctors,}, thread, stream_mode=\"values\"):\n",
    "    doctors = event.get('doctors', '')\n",
    "    if doctors:\n",
    "        for doctor in doctors:\n",
    "            print(f\"Name: {doctor.name}\")\n",
    "            print(f\"Experience(in years): {doctor.experience}\")\n",
    "            print(f\"Qualification: {doctor.qualifications}\")\n",
    "            print(f\"Specialization: {doctor.specialization}\")\n",
    "            print(f\"Description: {doctor.description}\")\n",
    "            print(\"-\" * 50)  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "8a04df8c-bc52-4f64-8bd9-2f12e2660652",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('human_feedback',)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state = graph.get_state(thread)\n",
    "state.next"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "32ef6792-8589-40d1-aef9-e05c335f8160",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'configurable': {'thread_id': '1',\n",
       "  'checkpoint_ns': '',\n",
       "  'checkpoint_id': '1f0ceda7-3817-6762-8002-b6bfb6ebd654'}}"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "graph.update_state(thread, {\"human_feedback\": \n",
    "                            \"Add a Lung cancer specialist\"}, as_node=\"human_feedback\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "3dbcfbdb-e3b0-49e8-94ae-7f77119c73bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Dr. Aisha Rahman\n",
      "Experience(in years): 14\n",
      "Qualification: MD, FCCP\n",
      "Specialization: Pulmonologist\n",
      "Description: Consultant Pulmonologist at City Respiratory & Sleep Center. Focuses on pleuritic chest pain, pneumonia, pulmonary embolism workups, and interventional bronchoscopy. Leads a multidisciplinary lung clinic and has authored guidelines on outpatient evaluation of pleuritic chest pain.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Michael Chen\n",
      "Experience(in years): 12\n",
      "Qualification: MD, FACEP\n",
      "Specialization: Emergency Medicine Physician\n",
      "Description: Attending physician in the Emergency Department at Metropolitan General Hospital. Expert in rapid assessment of acute chest and lung pain, including pneumothorax, pulmonary embolism, rib fractures, and pneumonia. Trained in point-of-care ultrasound and advanced cardiac life support protocols.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Sofia Alvarez\n",
      "Experience(in years): 16\n",
      "Qualification: MD, FACC\n",
      "Specialization: Cardiologist\n",
      "Description: Consultant Cardiologist at Heart & Vascular Institute. Specializes in differentiating cardiac causes of chest pain from pulmonary etiologies, including ischemic heart disease and pericarditis. Oversees a chest pain unit and integrates ECG, echocardiography, and CT angiography into diagnostic pathways.\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "for event in graph.stream(None, thread, stream_mode=\"values\"):\n",
    "    doctors = event.get('doctors', '')\n",
    "    if doctors:\n",
    "        for doctor in doctors:\n",
    "            print(f\"Name: {doctor.name}\")\n",
    "            print(f\"Experience(in years): {doctor.experience}\")\n",
    "            print(f\"Qualification: {doctor.qualifications}\")\n",
    "            print(f\"Specialization: {doctor.specialization}\")\n",
    "            print(f\"Description: {doctor.description}\")\n",
    "            print(\"-\" * 50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "c47b39c8-cde0-47e0-91dd-734ac2813e75",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'configurable': {'thread_id': '1',\n",
       "  'checkpoint_ns': '',\n",
       "  'checkpoint_id': '1f0ceda7-3863-63aa-8003-21cd667d725d'}}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "further_feedack = None\n",
    "graph.update_state(thread, {\"human_feedback\": \n",
    "                            further_feedack}, as_node=\"human_feedback\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "f814cde1-9c42-4d1b-a183-519d3b683afd",
   "metadata": {},
   "outputs": [],
   "source": [
    "for event in graph.stream(None, thread, stream_mode=\"updates\"):\n",
    "    print(\"--Node--\")\n",
    "    node_name = next(iter(event.keys()))\n",
    "    print(node_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "f8536527-4a40-4fd6-afe0-f862633a0608",
   "metadata": {},
   "outputs": [],
   "source": [
    "final_state = graph.get_state(thread)\n",
    "doctors = final_state.values.get('doctors')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "bfa64fbb-63e0-4833-8c3d-c2ba40a70df2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "()"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final_state.next"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "3fa273c3-874d-47e0-b123-c5455f6ccec1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Dr. Aisha Rahman\n",
      "Experience(in years): 14\n",
      "Qualification: MD, FCCP\n",
      "Specialization: Pulmonologist\n",
      "Description: Consultant Pulmonologist at City Respiratory & Sleep Center. Focuses on pleuritic chest pain, pneumonia, pulmonary embolism workups, and interventional bronchoscopy. Leads a multidisciplinary lung clinic and has authored guidelines on outpatient evaluation of pleuritic chest pain.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Michael Chen\n",
      "Experience(in years): 12\n",
      "Qualification: MD, FACEP\n",
      "Specialization: Emergency Medicine Physician\n",
      "Description: Attending physician in the Emergency Department at Metropolitan General Hospital. Expert in rapid assessment of acute chest and lung pain, including pneumothorax, pulmonary embolism, rib fractures, and pneumonia. Trained in point-of-care ultrasound and advanced cardiac life support protocols.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Sofia Alvarez\n",
      "Experience(in years): 16\n",
      "Qualification: MD, FACC\n",
      "Specialization: Cardiologist\n",
      "Description: Consultant Cardiologist at Heart & Vascular Institute. Specializes in differentiating cardiac causes of chest pain from pulmonary etiologies, including ischemic heart disease and pericarditis. Oversees a chest pain unit and integrates ECG, echocardiography, and CT angiography into diagnostic pathways.\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "for doctor in doctors:\n",
    "    print(f\"Name: {doctor.name}\")\n",
    "    print(f\"Experience(in years): {doctor.experience}\")\n",
    "    print(f\"Qualification: {doctor.qualifications}\")\n",
    "    print(f\"Specialization: {doctor.specialization}\")\n",
    "    print(f\"Description: {doctor.description}\")\n",
    "    print(\"-\" * 50) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "92103f37-9fec-495c-aedf-ddcd48dc3b71",
   "metadata": {},
   "outputs": [],
   "source": [
    "# planning on arriving at result with the help of debates between the professionals.\n",
    "import operator\n",
    "from typing import  Annotated\n",
    "from langgraph.graph import MessagesState\n",
    "\n",
    "class DebateState(MessagesState):\n",
    "    max_num_turns: int \n",
    "    context: Annotated[list, operator.add] \n",
    "    doctors: list\n",
    "    debate: str \n",
    "    sections: list \n",
    "\n",
    "class SearchQuery(BaseModel):\n",
    "    search_query: str = Field(None, description=\"Search query for retrieval.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "3ad005b3-3990-46be-8bdc-00a5959bd0f4",
   "metadata": {},
   "outputs": [],
   "source": [
    "debate_instructions = \"\"\"You are to initiate a discussion between multiple doctors to diagnose the given symptom. \n",
    "\n",
    "Your goal is to get all of them to justify their approach and try to convince the other doctors why their way is the best. Be open to all ideas and decide the best way.\n",
    "\n",
    "1. Take turns: Have a back and forth with the other specialists on how to diagnose and treat the symptom.\n",
    "        \n",
    "2. Specific: Insights that avoid generalities and include specific knowledge from each induviduals field.\n",
    "\n",
    "Here is your topic of focus and set of goals for each doctor: {goals}\n",
    "        \n",
    "Begin by introducing yourself using a name that fits your persona, and then make your case.\n",
    "\n",
    "Continue to ask questions to drill down and refine your treatment plan for the patient.\n",
    "\n",
    "You are to make judgments based on just the symptoms of the patient, if there is any uncertainty (i.e. gender, age, history), you are to provide answers for all cases to be as all-encompassing as possible\n",
    "        \n",
    "When you are satisfied with your plan, complete the debate with: \"Thank you!\"\n",
    "\n",
    "Remember to stay in character throughout your response, reflecting the persona and goals provided to you.\"\"\"\n",
    "\n",
    "def generate_discussion(state: DebateState):\n",
    "    \"\"\" Node to generate a discussion \"\"\"\n",
    "\n",
    "    doctors = state[\"doctors\"]\n",
    "    messages = state[\"messages\"]\n",
    " \n",
    "    system_message = debate_instructions.format(goals={doctor1.persona,doctor2.persona,doctor3.persona})\n",
    "    sentence = llm.invoke([SystemMessage(content=system_message)]+messages)\n",
    "        \n",
    "    return {\"messages\": [sentence]}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "bd1ff221-cf4e-429c-a6d6-e8481a34234d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# testing out a smaple debate by making a temporary graph for debate\n",
    "\n",
    "builder = StateGraph(DebateState)\n",
    "\n",
    "builder.add_node(\"debate_step\", generate_discussion)\n",
    "builder.add_edge(START, \"debate_step\")\n",
    "def should_continue(state):\n",
    "    # stop if \"Thank you!\" appears OR turns exceeded\n",
    "    last_message = state[\"messages\"][-1].content.lower()\n",
    "\n",
    "    if \"thank you\" in last_message:\n",
    "        return END\n",
    "    if len(state[\"messages\"]) >= state[\"max_num_turns\"]:\n",
    "        return END\n",
    "    return \"debate_step\"\n",
    "builder.add_conditional_edges(\n",
    "    \"debate_step\",\n",
    "    should_continue,\n",
    "    [\"debate_step\", END]\n",
    ")\n",
    "\n",
    "memory = MemorySaver()\n",
    "graph = builder.compile(interrupt_before=[], checkpointer=memory)\n",
    "\n",
    "from IPython.display import Image, display\n",
    "\n",
    "display(Image(graph.get_graph(xray=1).draw_mermaid_png()))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "206bc3e6-2903-4d46-98f7-7286033c99d4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "----------------------------------------------\n",
      "The patient has pleuritic chest pain and cough.\n",
      "\n",
      "----------------------------------------------\n",
      "I’m Dr. Michael Chen, Emergency Medicine. Pleuritic chest pain with cough makes me immediately consider pulmonary embolism (PE), pneumonia, pneumothorax, viral pleurisy, and pericarditis; I also won’t ignore atypical ACS. My ED-first moves are rapid and specific:\n",
      "- Triage: ABCs, O2 sat, heart rate, blood pressure, temperature, respiratory rate. Place on a monitor and give supplemental O2 if SpO2 < 92%.\n",
      "- Tests in the first 10 minutes: 12‑lead ECG, bedside lung/heart ultrasound (look for absent lung sliding/“barcode” for pneumothorax, B‑lines or consolidation for pneumonia, right heart strain, and pericardial effusion), chest X‑ray, high‑sensitivity troponin, CBC, BMP, CRP, and viral panel (COVID/flu/RSV). Pregnancy test if relevant.\n",
      "- Risk stratify for PE using history + exam. If low pretest probability and PERC negative, no D‑dimer; otherwise D‑dimer (age‑adjusted if >50: age×10 ng/mL FEU) and proceed to CT pulmonary angiography (CTPA) if positive. In pregnancy or severe renal insufficiency, consider V/Q scan.\n",
      "- Immediate treatment pivots on diagnosis: tension pneumothorax → needle decompression; hypoxemic PE with shock → thrombolysis; bacterial pneumonia with sepsis → IV antibiotics/fluids.\n",
      "\n",
      "Questions to narrow things down:\n",
      "- How old is the patient and what are the vitals (HR, BP, RR, SpO2, Temp)?\n",
      "- Any risk factors for PE: calf pain/swelling, hemoptysis, recent surgery/immobilization, estrogen therapy, pregnancy/postpartum, prior DVT/PE, active cancer, long travel?\n",
      "- Fever, rigors, or purulent sputum? Pleuritic pain focal to one side? Pleuritic rub?\n",
      "- Recent viral illness, positional pain better leaning forward, or pericardial friction rub?\n",
      "- Pleuritic pain after sudden cough or trauma (rib fracture/pneumothorax)? Chest wall tenderness?\n",
      "- Rash in a dermatomal band (zoster)?\n",
      "\n",
      "Dr. Aisha Rahman, Pulmonology here. Pleuritic pain plus cough is pulmonary until proven otherwise. My differential priority:\n",
      "- High-stakes: PE and pneumothorax.\n",
      "- Common: community‑acquired pneumonia (CAP), viral pleurisy, acute bronchitis.\n",
      "- Others: pleural effusion (parapneumonic, PE, malignancy), asthma/COPD exacerbation, zoster.\n",
      "\n",
      "My pathway:\n",
      "- PE: Use Wells or YEARS to set pretest probability. If low and PERC negative (no hemoptysis, no estrogen use, age < 50, HR < 100, SpO2 ≥ 95%, no unilateral leg swelling, no recent surgery/trauma, no prior VTE), stop—no D‑dimer. Otherwise, D‑dimer (age‑adjusted). Positive → CTPA; if pregnant or CrCl < 30, V/Q with CXR guidance. If CTPA negative but DVT signs present, bilateral leg ultrasound.\n",
      "- Pneumonia vs viral pleurisy: CXR first. Focal lobar opacity, fever, HR ≥ 100, RR ≥ 24, or crackles/egophony support CAP. Normal CXR with URI symptoms suggests viral pleurisy/bronchitis.\n",
      "  - Outpatient CAP (no comorbidities): amoxicillin 1 g three times daily or doxycycline 100 mg twice daily; or azithromycin if low macrolide resistance.\n",
      "  - With comorbidities (chronic heart/lung/liver/renal disease, diabetes, alcoholism, malignancy): amoxicillin‑clavulanate 875/125 mg twice daily plus azithromycin 500 mg day 1 then 250 mg daily; or levofloxacin 750 mg daily. Duration 5 days minimum if afebrile and improving.\n",
      "  - Consider procalcitonin to support de‑escalation but not to withhold initial therapy in moderate/severe disease.\n",
      "- Pneumothorax: Lung ultrasound is faster than CXR. If stable small primary pneumothorax (<2 cm at hilum), observe with O2 and repeat imaging in 4–6 hours; larger or symptomatic → needle aspiration or pigtail/chest tube. Tension physiology? Immediate needle decompression then tube thoracostomy.\n",
      "- Pleural effusion: If moderate/large and undiagnosed, ultrasound‑guided diagnostic thoracentesis (Light’s criteria) and send fluid for protein, LDH, pH, glucose, cell count, Gram stain/culture, cytology.\n",
      "- Symptom control: NSAIDs for pleurisy; inhaled bronchodilators if wheezy; incentive spirometry if rib pain to prevent atelectasis.\n",
      "\n",
      "I’d like details on fever, sputum character, pleuritic laterality, leg swelling, and oxygenation. If you push CTPA on low‑risk, PERC‑negative patients, you increase false positives and radiation—so let’s be judicious.\n",
      "\n",
      "Dr. Sofia Alvarez, Cardiology. Pleuritic pain is often non‑cardiac, but I need to exclude pericarditis/myopericarditis and ensure we don’t miss ACS masquerading as “pleuritic.”\n",
      "- ECG specifics:\n",
      "  - Pericarditis: diffuse concave ST elevation with PR depression, reciprocal PR elevation and ST depression in aVR/V1; no localized reciprocal ST depression as in STEMI.\n",
      "  - PE: sinus tachycardia, S1Q3T3, right axis, incomplete RBBB, T‑wave inversions V1–V4; look for RV strain.\n",
      "  - ACS: regional ST changes corresponding to a territory; pleuritic quality makes ACS less likely but not impossible.\n",
      "- Labs: high‑sensitivity troponin (repeat at 0 and 1–2 hours), CRP/ESR. Troponin can be mildly elevated in myopericarditis—context and echo matter.\n",
      "- Echo: I want focused echo early. Findings: pericardial effusion, RV dilation and septal flattening (PE), LV regional wall motion abnormality (ACS).\n",
      "- Pericarditis management: if clinical triad (pleuritic chest pain improved leaning forward, pericardial rub, typical ECG) and supportive labs/echo, treat with high‑dose NSAID (ibuprofen 600–800 mg TID) plus colchicine (0.5 mg BID if >70 kg, daily if ≤70 kg) for 3 months; add PPI; restrict strenuous activity. Avoid anticoagulation if large effusion/tamponade risk unless there is proven PE or another compelling indication. Red flags for admission: fever >38°C, subacute onset, large effusion, immunosuppression, anticoagulation, elevated troponin, trauma, or lack of response to NSAIDs.\n",
      "- If you suspect myocarditis (chest pain, elevated troponin, diffuse ST changes) with viral prodrome and cough—cardiac MRI is confirmatory, but we stabilize first.\n",
      "\n",
      "I agree with Dr. Rahman on using decision rules to limit unnecessary CT, but I’ll push for early ECG/echo on everyone with pleuritic chest pain, because pericarditis is easy to miss and has specific therapy. I also want to caution: anticoagulating a patient with unrecognized large pericardial effusion can precipitate tamponade—so a quick echo before empiric anticoagulation, when feasible, is valuable unless the patient is crashing from suspected massive PE.\n",
      "\n",
      "Dr. Chen (EM) to both: For the unstable patient (hypotension, hypoxia, altered mentation), we prioritize life threats:\n",
      "- Suspected tension pneumothorax → needle decompression now, don’t wait for imaging.\n",
      "- Suspected massive PE with shock and RV strain on bedside echo → thrombolysis if no absolute contraindication.\n",
      "- Tamponade signs (hypotension, JVD, muffled heart sounds) with large effusion on echo → pericardiocentesis.\n",
      "For the stable patient, I’ll follow Dr. Rahman’s PE algorithm with PERC/Wells and integrate Dr. Alvarez’s ECG/echo cues to catch pericarditis or RV strain early.\n",
      "\n",
      "Dr. Rahman challenges: If the CXR is normal, vitals are normal, PERC negative, and pain is sharp and worse with inspiration after a viral URI, I’d avoid D‑dimer and CT. Treat as viral pleurisy: NSAIDs, rest, and return precautions. Agree?\n",
      "Dr. Chen: Yes—provided no red flags (tachycardia, hypoxia, hemoptysis, unilateral leg swelling, high-risk history).\n",
      "Dr. Alvarez: Agreed, but I still want a quick ECG; if there’s PR depression or diffuse ST elevation, that pivots to pericarditis therapy.\n",
      "\n",
      "What we need from you to finalize:\n",
      "- Age/sex, pregnancy status if applicable.\n",
      "- Vitals (HR, BP, RR, Temp, SpO2).\n",
      "- Character of pain (side, sharpness, worse with deep breath/cough, better leaning forward).\n",
      "- Associated symptoms (fever, sputum, hemoptysis, dyspnea, syncope, leg swelling, recent travel/surgery, OCP/estrogen use, cancer history, trauma).\n",
      "- Any rash or chest wall tenderness.\n",
      "\n",
      "Provisional plan now (without your specifics):\n",
      "- Everyone gets ECG and CXR; basic labs; viral testing during respiratory season. Bedside lung/heart ultrasound if available.\n",
      "- If low PE risk and PERC negative with normal CXR and stable vitals: likely viral pleurisy or bronchitis. NSAIDs (e.g., ibuprofen 400–600 mg every 6–8 h with food), hydration, cough support (honey, dextromethorphan PRN), avoid antibiotics, recheck in 48–72 hours or sooner if worse.\n",
      "- If pneumonia on CXR or strong clinical suspicion:\n",
      "  - Outpatient, healthy: amoxicillin 1 g TID or doxycycline 100 mg BID for 5 days; add albuterol if bronchospasm.\n",
      "  - With comorbidities: amoxicillin‑clavulanate 875/125 mg BID plus azithromycin; or levofloxacin 750 mg daily. Admit if CURB‑65 ≥ 2, SpO2 < 90%, RR ≥ 30, SBP < 90, confusion, or inability to maintain oral intake.\n",
      "- If PE likely or D‑dimer positive: CTPA (or V/Q). If confirmed and hemodynamically stable: start a DOAC (e.g., apixaban 10 mg BID for 7 days then 5 mg BID), assess for provoking factors and bleeding risk; unstable: consider thrombolysis.\n",
      "- If pneumothorax: manage per size and stability as above.\n",
      "- If pericarditis: NSAID + colchicine, PPI, activity restriction; admit if red flags; avoid anticoagulation unless needed for proven VTE.\n",
      "\n",
      "Safety net:\n",
      "- Go to ED immediately for worsening shortness of breath, fainting, chest pain at rest, new leg swelling, hemoptysis, SpO2 < 92% at rest, or high fever not improving in 48 hours.\n",
      "\n",
      "Please share the details I asked for so we can tailor this to you precisely and choose the right branch of the plan. Thank you!\n"
     ]
    }
   ],
   "source": [
    "# Input\n",
    "doctor1=doctors[0]\n",
    "doctor2=doctors[1]\n",
    "doctor3=doctors[2]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"2\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": \"The patient has pleuritic chest pain and cough.\"}\n",
    "    ],\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "\n",
    "for event in graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    if \"messages\" in event:\n",
    "        print(\"\\n----------------------------------------------\")\n",
    "        print(event[\"messages\"][-1].content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "9e977c2e-52d8-481a-a07f-5e17071e364c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "TAVILY_API_KEY:  ········\n"
     ]
    }
   ],
   "source": [
    "# integration of web search\n",
    "\n",
    "def _set_env(var: str):\n",
    "    if not os.environ.get(var):\n",
    "        os.environ[var] = getpass.getpass(f\"{var}: \")\n",
    "\n",
    "_set_env(\"TAVILY_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "41ff1bda-7315-4453-8d49-75b443f9bd80",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\hp\\AppData\\Local\\Temp\\ipykernel_32532\\3381304624.py:2: LangChainDeprecationWarning: The class `TavilySearchResults` was deprecated in LangChain 0.3.25 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-tavily package and should be used instead. To use it run `pip install -U :class:`~langchain-tavily` and import as `from :class:`~langchain_tavily import TavilySearch``.\n",
      "  tavily_search = TavilySearchResults(max_results=3)\n"
     ]
    }
   ],
   "source": [
    "from langchain_community.tools.tavily_search import TavilySearchResults\n",
    "tavily_search = TavilySearchResults(max_results=3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "cb8b7bac-ac19-48bf-b576-f01f4998e862",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_community.document_loaders import WikipediaLoader"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "562dcdb3-11fc-4cee-b8d7-6a189d2ab595",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from langchain_core.messages import get_buffer_string\n",
    "\n",
    "search_instructions = SystemMessage(content=f\"\"\"You will be given a conversation between medical experts diagnosing a symptom. \n",
    "\n",
    "Your goal is to generate a well-structured query for use in retrieval and / or web-search related to the conversation.\n",
    "        \n",
    "First, analyze the full conversation.\n",
    "\n",
    "Pay particular attention to the treatment plan posed by each doctor.\n",
    "\n",
    "Verify this final plan using a well-structured web search query\"\"\")\n",
    "\n",
    "def search_web(state: DebateState):\n",
    "\n",
    "    structured_llm = llm.with_structured_output(SearchQuery)\n",
    "    search_query = structured_llm.invoke([search_instructions] + state['messages'])\n",
    "\n",
    "    search_docs = tavily_search.invoke(search_query.search_query)\n",
    "\n",
    "    if isinstance(search_docs, dict) and \"results\" in search_docs:\n",
    "        search_docs = search_docs[\"results\"]\n",
    "\n",
    "    formatted = []\n",
    "\n",
    "    for doc in search_docs:\n",
    "        if isinstance(doc, dict):\n",
    "            url = doc.get(\"url\", \"unknown\")\n",
    "            content = doc.get(\"content\", str(doc))\n",
    "            formatted.append(\n",
    "                f'<Document href=\"{url}\">\\n{content}\\n</Document>'\n",
    "            )\n",
    "        else:\n",
    "            formatted.append(\n",
    "                f'<Document>\\n{str(doc)}\\n</Document>'\n",
    "            )\n",
    "\n",
    "    return {\"context\": [\"\\n\\n---\\n\\n\".join(formatted)]}\n",
    "\n",
    "\n",
    "def search_wikipedia(state: DebateState):\n",
    "    \n",
    "    \"\"\" Retrieve docs from wikipedia \"\"\"\n",
    "\n",
    "    structured_llm = llm.with_structured_output(SearchQuery)\n",
    "    search_query = structured_llm.invoke([search_instructions]+state['messages'])\n",
    "    \n",
    "    search_docs = WikipediaLoader(query=search_query.search_query, \n",
    "                                  load_max_docs=3).load()\n",
    "\n",
    "    formatted_search_docs = \"\\n\\n---\\n\\n\".join(\n",
    "        [\n",
    "            f'<Document source=\"{doc.metadata[\"source\"]}\" page=\"{doc.metadata.get(\"page\", \"\")}\"/>\\n{doc.page_content}\\n</Document>'\n",
    "            for doc in search_docs\n",
    "        ]\n",
    "    )\n",
    "\n",
    "    return {\"context\": [formatted_search_docs]} \n",
    "\n",
    "def merge_search_results(state: DebateState):\n",
    "    merged = \"\\n\\n\".join(state[\"context\"])\n",
    "    return {\"context\": [merged]}\n",
    "\n",
    "def generate_treatment_plan(state: DebateState):\n",
    "    \"\"\"\n",
    "    Node that merges:\n",
    "    - all debate conversation\n",
    "    - web + wikipedia search context\n",
    "    and generates a final, unified medical treatment plan.\n",
    "    \"\"\"\n",
    "\n",
    "    messages = state[\"messages\"]            \n",
    "    context_list = state.get(\"context\", []) \n",
    "    debate_topic = state.get(\"debate\", \"\")  \n",
    "    \n",
    "    context_text = \"\\n\\n\".join(context_list) if context_list else \"No external context available.\"\n",
    "    \n",
    "    system_message = \"\"\"You are a panel lead physician tasked with producing the *final medical treatment plan based on:\n",
    "\n",
    "    1. The entire debate between specialists.\n",
    "    2. The combined search context (clinical guidelines, web results, wikipedia summaries).\n",
    "    3. The patient’s main complaint: {debate_topic}\n",
    "\n",
    "    Your output must be:\n",
    "\n",
    "    - Structured\n",
    "    - Evidence-based\n",
    "    - Reflective of the discussion points raised by all specialists\n",
    "    - Clear and clinically actionable\n",
    "\n",
    "    DO NOT repeat the debate.\n",
    "    DO NOT repeat the search results.\n",
    "    Synthesize everything into a **single, authoritative treatment plan**.\n",
    "\n",
    "    Include:\n",
    "    - Primary diagnosis or differential\n",
    "    - Recommended diagnostic tests with justification\n",
    "    - Initial treatment\n",
    "    - Follow-up considerations\n",
    "    - Any red flags or escalation scenarios\n",
    "\n",
    "Finish with: “Final plan complete.”\n",
    "\"\"\"\n",
    "\n",
    "    final_response = llm.invoke([SystemMessage(content=system_message)] + messages)\n",
    "    final_response.name = \"treatment_plan\"\n",
    "\n",
    "    return {\"messages\": [final_response]}\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "# Add nodes and edges \n",
    "debate_builder = StateGraph(DebateState)\n",
    "debate_builder.add_node(\"debate_step\", generate_discussion)\n",
    "debate_builder.add_node(\"search_web\", search_web)\n",
    "debate_builder.add_node(\"search_wikipedia\", search_wikipedia)\n",
    "debate_builder.add_node(\"merge_search_results\", merge_search_results)\n",
    "debate_builder.add_node(\"generate_treatment_plan\", generate_treatment_plan)\n",
    "\n",
    "# Flow\n",
    "debate_builder.add_edge(START, \"debate_step\")\n",
    "debate_builder.add_edge(\"debate_step\", \"search_web\")\n",
    "debate_builder.add_edge(\"debate_step\", \"search_wikipedia\")\n",
    "debate_builder.add_edge(\"search_web\", \"merge_search_results\")\n",
    "debate_builder.add_edge(\"search_wikipedia\", \"merge_search_results\")\n",
    "debate_builder.add_edge(\"merge_search_results\", \"generate_treatment_plan\")\n",
    "debate_builder.add_edge(\"generate_treatment_plan\", END)\n",
    "\n",
    "# debate \n",
    "memory = MemorySaver()\n",
    "debate_graph = debate_builder.compile(checkpointer=memory).with_config(run_name=\"Conduct Debate\")\n",
    "\n",
    "# View\n",
    "display(Image(debate_graph.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "9f6b45e0-512c-469e-bd35-493e63b4752b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Final treatment plan for pleuritic chest pain with cough\n",
      "\n",
      "1) Working diagnosis and prioritized differential\n",
      "- Time-sensitive conditions to rule out first:\n",
      "  - Pulmonary embolism (PE)\n",
      "  - Pneumothorax\n",
      "  - Community-acquired pneumonia (CAP) with/without parapneumonic effusion/empyema\n",
      "  - Acute pericarditis or myopericarditis\n",
      "- Other likely benign causes (only after excluding above):\n",
      "  - Viral pleuritis\n",
      "  - Costochondritis/rib strain\n",
      "\n",
      "2) Diagnostic testing and justification\n",
      "Immediate (within minutes)\n",
      "- Vitals with pulse oximetry; consider arterial/venous blood gas if hypoxic or in distress.\n",
      "- 12‑lead ECG: exclude ischemia; identify pericarditis patterns; assess for right heart strain (possible PE).\n",
      "- Chest X‑ray (PA/lateral if stable; portable if unstable): look for consolidation, effusion, pneumothorax, alternative causes.\n",
      "- Point‑of‑care ultrasound (POCUS): assess lung sliding (pneumothorax), focal B‑lines/consolidation (pneumonia), pleural effusion; cardiac views for pericardial effusion/RV strain.\n",
      "- Pregnancy test in patients of childbearing potential (guides imaging/therapy).\n",
      "\n",
      "Laboratory\n",
      "- CBC, BMP, CRP; consider procalcitonin as adjunct in suspected pneumonia severity/antibiotic decisions.\n",
      "- Troponin with repeat if indicated (ACS rule-out; myopericarditis).\n",
      "- D‑dimer only if PE pre-test probability is low–intermediate (Wells/Geneva); use age‑adjusted threshold ≥50 years (age × 10 ng/mL FEU). If very low risk and PERC negative, no D‑dimer or imaging.\n",
      "- Viral PCR panel (COVID/Influenza/RSV) in respiratory season.\n",
      "- If moderate–severe pneumonia or admission: blood cultures (before antibiotics), sputum culture/Gram stain; consider urine antigens (Legionella, pneumococcus) if severe or exposure risks.\n",
      "\n",
      "Imaging algorithms\n",
      "- Suspected PE:\n",
      "  - High pretest probability: start anticoagulation (if no contraindication) and obtain CT pulmonary angiography (CTPA). If pregnant or CTPA contraindicated, use V/Q scan if CXR normal; bilateral leg compression ultrasound—if DVT proven, treat without chest CT.\n",
      "  - Low–intermediate probability with positive D‑dimer: CTPA (or V/Q as above).\n",
      "- Suspected pericarditis: transthoracic echocardiogram to evaluate for effusion/tamponade; trend CRP/troponin. Consider cardiac MRI if myocarditis suspected or diagnostic uncertainty.\n",
      "- Pleural effusion (moderate/large or loculated on imaging): diagnostic thoracentesis with cell count/differential, protein/LDH (Light’s criteria), pH, glucose, Gram stain/culture; cytology if malignancy risk.\n",
      "- Pneumothorax: confirm with CXR; use POCUS for rapid diagnosis; chest CT if equivocal or underlying lung disease suspected.\n",
      "\n",
      "3) Initial treatment (by likely diagnosis)\n",
      "General measures for all\n",
      "- Oxygen to maintain SpO2 ≥94% (88–92% if chronic hypercapnic COPD).\n",
      "- Analgesia: acetaminophen and/or NSAID if no contraindication; add PPI with high-dose NSAIDs.\n",
      "- Early mobilization and incentive spirometry if painful breathing to prevent atelectasis.\n",
      "\n",
      "Pulmonary embolism\n",
      "- Anticoagulation (if no active bleeding/high bleeding risk):\n",
      "  - Apixaban 10 mg BID x 7 days, then 5 mg BID; or\n",
      "  - Rivaroxaban 15 mg BID x 21 days, then 20 mg daily.\n",
      "  - Cancer: LMWH preferred (e.g., enoxaparin 1 mg/kg BID).\n",
      "  - Pregnancy: LMWH; avoid DOACs.\n",
      "- Admit if hypotension, hypoxemia requiring oxygen, RV strain, elevated cardiac biomarkers, high PESI/sPESI, or poor support. Consider outpatient for stable low-risk PE with reliable follow-up.\n",
      "- Massive/submassive PE with hemodynamic compromise: urgent specialist team; consider systemic thrombolysis or catheter-directed therapy.\n",
      "\n",
      "Community-acquired pneumonia\n",
      "- Outpatient, no comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID; minimum 5 days and until clinically stable 48–72 hours.\n",
      "- Outpatient with comorbidities (chronic heart/lung/liver/renal, diabetes, alcoholism, malignancy, asplenia): amoxicillin‑clavulanate 875/125 mg BID plus azithromycin (500 mg day 1, then 250 mg daily x 4) or doxycycline; alternative monotherapy levofloxacin 750 mg daily x 5 if beta‑lactam allergy.\n",
      "- Inpatient (non‑ICU): ceftriaxone plus azithromycin, or levofloxacin monotherapy. Add MRSA/Pseudomonas coverage only with specific risk factors.\n",
      "- Complicated effusion/empyema: urgent chest tube drainage; intrapleural tPA/DNase as indicated; surgical consult if not resolving.\n",
      "\n",
      "Pneumothorax\n",
      "- Small, primary, minimally symptomatic: observe with oxygen; repeat CXR in 4–6 hours; discharge if stable and improving with return precautions.\n",
      "- Large, symptomatic, secondary (e.g., COPD), or any instability: needle aspiration or small‑bore chest tube; admit. Avoid air travel until radiographic resolution; no diving until specialist clearance. Counsel smoking/vaping cessation.\n",
      "\n",
      "Acute pericarditis (no red flags)\n",
      "- Ibuprofen 600–800 mg three times daily or high‑dose aspirin; taper over weeks guided by symptom resolution and CRP.\n",
      "- Colchicine 0.5 mg BID if >70 kg or 0.5 mg daily if ≤70 kg for 3 months.\n",
      "- Activity restriction; avoid strenuous exercise until symptom and CRP resolution (≥3 months; longer if myocarditis).\n",
      "- If myopericarditis (elevated troponin/LV dysfunction): admit for monitoring; cautious use of NSAIDs, tailor to myocardial involvement; consider cardiac MRI; start guideline‑directed therapy if LV dysfunction.\n",
      "\n",
      "Viral pleuritis/costochondritis (diagnosis of exclusion)\n",
      "- NSAIDs, topical lidocaine or heat/ice; gentle stretching; cough suppression (e.g., dextromethorphan) for sleep as needed.\n",
      "- Reassess in 48–72 hours; escalate if not improving.\n",
      "\n",
      "Special situations\n",
      "- Pregnancy: use pregnancy‑adapted diagnostic algorithms for PE; prefer V/Q scan if CXR normal; anticoagulate with LMWH only; avoid NSAIDs in 3rd trimester.\n",
      "- Immunocompromised or TB risk: broaden infectious workup; early chest CT and specialist input.\n",
      "\n",
      "4) Disposition and follow‑up\n",
      "- Reassess outpatients within 48–72 hours (earlier if worsening).\n",
      "- Pneumonia: ensure clinical improvement; adjust/de‑escalate antibiotics with culture results; repeat CXR in ~6 weeks for age >50, smokers, or persistent symptoms to exclude underlying malignancy.\n",
      "- PE: anticoagulation education (bleeding precautions, drug interactions), follow‑up in 1–2 weeks to review tolerance and results; plan total duration (minimum 3 months for provoked; longer if unprovoked/high risk). Consider contraception change if estrogen‑related; avoid long immobility; arrange cancer screening if indicated.\n",
      "- Pericarditis: follow CRP weekly until normal; cardiology follow‑up in 1–2 weeks; echo if persistent effusion or symptoms; gradual NSAID taper.\n",
      "- Pneumothorax: imaging until full resolution; thoracic surgery referral for recurrent events or persistent air leak.\n",
      "- Preventive care: influenza and pneumococcal vaccination as indicated; smoking cessation support.\n",
      "\n",
      "5) Red flags and escalation\n",
      "- Immediate ED/ICU escalation for any of:\n",
      "  - Hemodynamic instability (SBP <90, syncope), severe or worsening hypoxemia, respiratory distress.\n",
      "  - Signs of tension pneumothorax (sudden deterioration, unilateral absent breath sounds, hypotension) → emergent decompression.\n",
      "  - Massive PE signs (hypotension, syncope, new RV strain) → urgent anticoagulation and thrombolysis consideration.\n",
      "  - Tamponade signs (hypotension, JVD, muffled heart sounds) → urgent pericardiocentesis.\n",
      "  - Sepsis criteria, altered mental status, new hemoptysis, rapidly enlarging pleural effusion, or chest pain with dynamic ECG/troponin changes.\n",
      "\n",
      "This plan prioritizes rapid exclusion of life‑threatening disease while providing targeted testing and treatment pathways for the most likely etiologies of pleuritic chest pain with cough. Final plan complete.\n"
     ]
    }
   ],
   "source": [
    "# Input\n",
    "doctor1=doctors[0]\n",
    "doctor2=doctors[1]\n",
    "doctor3=doctors[2]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"2\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": \"The patient has pleuritic chest pain and cough.\"}\n",
    "    ],\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "\n",
    "final_plan = None\n",
    "\n",
    "for event in debate_graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    if \"messages\" in event:\n",
    "        msg = event[\"messages\"][-1]\n",
    "\n",
    "        if getattr(msg, \"name\", None) == \"treatment_plan\":\n",
    "            final_plan = msg.content\n",
    "\n",
    "# Print only the final treatment plan\n",
    "print(final_plan)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "33d2a5e3-8a52-412e-82cd-5ef35e3e57d2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from dataclasses import dataclass, field\n",
    "@dataclass\n",
    "class FinalState:\n",
    "    symptom: str \n",
    "    max_doctors: int  \n",
    "    doctors: List[Doctor]\n",
    "    max_num_turns: int \n",
    "    context: Annotated[list, operator.add] \n",
    "    doctors: list\n",
    "    debate: str \n",
    "    sections: list\n",
    "    \n",
    "\n",
    "def bridge(FinalState):\n",
    "    return FinalState\n",
    "\n",
    "full_builder = StateGraph(FinalState)\n",
    "full_builder.add_node(\"create_doctors\", create_doctors)\n",
    "#full_builder.add_node(\"human_feedback\", human_feedback)\n",
    "\n",
    "full_builder.add_node(\"bridge\",bridge)\n",
    "\n",
    "full_builder.add_node(\"debate_step\", generate_discussion)\n",
    "full_builder.add_node(\"search_web\", search_web)\n",
    "full_builder.add_node(\"search_wikipedia\", search_wikipedia)\n",
    "full_builder.add_node(\"merge_search_results\", merge_search_results)\n",
    "full_builder.add_node(\"generate_treatment_plan\", generate_treatment_plan)\n",
    "\n",
    "# Flow\n",
    "full_builder.add_edge(START, \"create_doctors\")\n",
    "full_builder.add_edge(\"create_doctors\", \"bridge\")\n",
    "#full_builder.add_conditional_edges(\"human_feedback\", should_continue, [\"create_doctors\", \"bridge\"])\n",
    "\n",
    "\n",
    "\n",
    "full_builder.add_edge(\"bridge\", \"debate_step\")\n",
    "full_builder.add_edge(\"debate_step\", \"search_web\")\n",
    "full_builder.add_edge(\"debate_step\", \"search_wikipedia\")\n",
    "full_builder.add_edge(\"search_web\", \"merge_search_results\")\n",
    "full_builder.add_edge(\"search_wikipedia\", \"merge_search_results\")\n",
    "full_builder.add_edge(\"merge_search_results\", \"generate_treatment_plan\")\n",
    "full_builder.add_edge(\"generate_treatment_plan\", END)\n",
    "\n",
    "# debate \n",
    "memory = MemorySaver()\n",
    "final_graph = full_builder.compile(checkpointer=memory).with_config(run_name=\"Full run\")\n",
    "\n",
    "# View\n",
    "display(Image(final_graph.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5d808d56-a7e3-4d51-8f31-522b4206e700",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter symptom I have ear ache\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['symptom', 'max_doctors', 'doctors', 'max_num_turns', 'context', 'debate', 'sections', 'messages'])\n",
      "[Doctor(name='Dr. Maya R. Chen', qualifications='MD, FACS (Otolaryngology—Head & Neck Surgery)', specialization='Otolaryngologist (ENT)', experience=14, description='Board-certified otolaryngologist at Metropolitan Ear, Nose & Throat Center. Manages acute and chronic ear pain, otitis media/externa, Eustachian tube dysfunction, and perforated eardrums. Leads a same-day ear pain clinic and has published on topical therapies for swimmer’s ear.'), Doctor(name='Dr. Arjun K. Patel', qualifications='MD, Fellowship in Otology/Neurotology', specialization='Otologist/Neurotologist', experience=12, description='Subspecialized ear surgeon at University Hearing & Balance Institute. Expertise in chronic ear infections, cholesteatoma, tympanoplasty, mastoid surgery, and complex otalgia with associated hearing or balance issues. Runs a multidisciplinary ear clinic for difficult cases.'), Doctor(name='Dr. Sofia L. Martinez', qualifications='DDS, MD (Oral & Maxillofacial Surgery)', specialization='Oral and Maxillofacial Surgeon (TMJ/Dental)', experience=11, description='OMFS at Downtown Oral & Facial Surgery Group. Evaluates dental and temporomandibular joint causes of ear pain, including bruxism, impacted molars, and occlusal disorders. Collaborates with ENT for referred otalgia and offers minimally invasive TMJ therapies.')]\n",
      "[AIMessage(content='Hi, I’m Dr. Michael Chen, Emergency Medicine. Let’s tackle acute pleuritic chest pain (sharp pain worse with deep breaths/coughing/movement). I’ll orchestrate an ED-first pathway that rapidly separates life threats (PE, pneumothorax, ACS, pericarditis, aortic dissection, pneumonia with sepsis) from benign causes (costochondritis, viral pleurisy).\\n\\nInitial ED priorities (first 10 minutes):\\n- Vitals, pulse oximetry, IV access, ECG, cardiac troponin, bedside glucose if altered.\\n- Focused exam: breath sounds (asymmetry?), JVD, calf swelling/tenderness, chest wall tenderness, fever, rash (zoster), neurologic deficits, new murmur.\\n- Point-of-care ultrasound (POCUS): lung sliding (pneumothorax), B-lines vs consolidation, IVC size/collapsibility, focused echo for pericardial effusion and RV strain; 2-point DVT scan.\\n\\nQuestions to the patient (please answer if you can; if not, we’ll plan for both branches):\\n- Onset: sudden vs gradual? Any trauma or recent vigorous cough?\\n- Pleuritic? Positional relief leaning forward?\\n- Dyspnea, syncope, hemoptysis?\\n- Fever, chills, productive cough, sick contacts, recent COVID/flu?\\n- Leg swelling/pain, recent surgery/immobilization, cancer, pregnancy/postpartum, OCP/estrogen?\\n- History of asthma/COPD, prior pneumothorax, smoking/vaping, tall/thin body habitus?\\n- Cardiovascular risks: age >50, diabetes, HTN, hyperlipidemia, known CAD, cocaine use.\\n- “Tearing” pain radiating to back, neuro symptoms, pulse differences (aortic dissection clues).\\n\\nNow I’ll invite my colleagues.\\n\\nDr. Sofia Alvarez, Cardiologist: I’m Sofia Alvarez. My priority is excluding ACS, pericarditis, and aortic dissection that can masquerade as pleuritic pain.\\n- ECG: \\n  - STEMI/NSTEMI features; note that PE can cause sinus tachycardia, right heart strain (S1Q3T3, RBBB), and minor troponin rises—context matters.\\n  - Pericarditis: diffuse concave ST elevation with PR depression; reciprocal PR elevation in aVR; pain improves leaning forward; pericardial rub.\\n- Troponin: Use high-sensitivity 0/1-hour algorithm. Elevated troponin without ischemic ECG could be PE, myocarditis, demand ischemia. Delta change is key.\\n- Echo: \\n  - Regional wall motion abnormality → ischemia.\\n  - Pericardial effusion/tamponade or thickened pericardium → pericarditis/pericardial disease.\\n  - RV dilation/dysfunction (TAPSE low, septal flattening) → PE.\\n- Aortic dissection: If “ripping” pain, mediastinal widening, BP/pulse differential, neuro deficits: do not delay CTA aorta with contrast; consider bedside TTE/TEE if unstable.\\n- Chest pain unit pathway if low-intermediate ACS risk: if troponins negative and ECG non-ischemic, consider CT coronary angiography (onset >3 h, HR controlled) to definitively exclude obstructive CAD. Avoid this if high PE likelihood—choose CTA pulmonary first based on clinical cues.\\n\\nI disagree with overusing D-dimer in older patients without pre-test stratification; indiscriminate testing inflates CT scans. Establish ACS risk and PE pretest before labs guide you.\\n\\nDr. Aisha Rahman, Pulmonologist: I’m Aisha Rahman. Pleuritic pain is pulmonary until proven otherwise: PE, pneumonia, pneumothorax, and pleurisy.\\n- Pretest assessment for PE:\\n  - If no red flags and PE seems unlikely, apply PERC (age <50, HR <100, SaO2 ≥95%, no hemoptysis, no estrogen, no prior VTE, no recent surgery/trauma, no unilateral leg swelling). If PERC negative, no D-dimer or imaging.\\n  - If low/intermediate Wells/Geneva, order age-adjusted D-dimer (age×10 ng/mL FEU for ≥50 y). If negative, PE ruled out. If positive, proceed to imaging.\\n  - If high probability by Wells (≥6) or YEARS/pregnancy-adapted YEARS positive, start anticoagulation first if no contraindications and imaging is delayed.\\n- Imaging for suspected PE:\\n  - CTA pulmonary angiography (CTPA) is first-line.\\n  - V/Q scan favored in pregnancy, severe contrast allergy, or advanced CKD; normal CXR increases V/Q utility.\\n- Pneumothorax:\\n  - Risk factors: tall/thin young, smokers/vapers, COPD/asthma, connective tissue disorders, mechanical ventilation, recent procedures.\\n  - POCUS: absent lung sliding, barcode sign; CXR upright expiratory; CT if equivocal.\\n  - Tension physiology → immediate needle decompression then chest tube.\\n- Pneumonia/pleurisy:\\n  - Fever, productive cough, pleuritic pain, focal crackles, pleural rub; CXR consolidation or effusion. Procalcitonin can support but do not delay antibiotics if septic.\\n  - Consider parapneumonic effusion/empyema: ultrasound-guided thoracentesis if moderate-large effusion or clinical deterioration.\\n\\nI’d push to avoid CT in low-risk patients using PERC/D-dimer correctly, and to use pregnancy-adapted algorithms to reduce radiation.\\n\\nDr. Chen (EM): Let’s synthesize a stepwise plan with branches based on your answers.\\n\\nStep 1: Stabilize and screen life threats\\n- If unstable (hypotension, severe hypoxia, altered): airway/oxygen, IVF/pressors as indicated, immediate POCUS.\\n  - No lung sliding + hemodynamic compromise → tension pneumothorax: needle decompression then chest tube.\\n  - Pericardial effusion with tamponade → pericardiocentesis.\\n  - Massive PE physiology (RV strain, shock) → thrombolysis/catheter-directed therapy after team huddle; fibrinolysis if crashing and no absolute contraindications.\\n\\nStep 2: Parallel ED diagnostics for stable patients\\n- ECG, serial hs-troponins (0 and 1 hour), CBC, BMP, lactate if ill, D-dimer per risk, BNP if HF suspected, viral panel during outbreaks, pregnancy test if applicable.\\n- CXR early (pneumonia, pneumothorax, effusion, mediastinal width).\\n- POCUS: lung, echo, DVT scan.\\n\\nDecision nodes:\\n\\nA) Strongly ischemic features (cardiologist’s pathway)\\n- STEMI: aspirin 325 mg chewed, P2Y12 loading, anticoagulate, statin, emergent cath.\\n- NSTEMI/high-risk: heparin, anti-ischemic therapy, risk-stratified early invasive strategy.\\n- Pericarditis: NSAIDs (e.g., ibuprofen 600–800 mg TID) + colchicine (0.5–0.6 mg BID adjusted by weight/renal), PPI protection; avoid anticoagulation unless concurrent VTE. Admit if fever >38, large effusion, troponin rise, immunosuppressed, anticoagulated, trauma, or failure of NSAIDs.\\n\\nB) Suspected PE (pulmonologist’s pathway)\\n- Pretest:\\n  - Low risk and PERC negative → no D-dimer, no imaging; consider musculoskeletal/viral pleurisy.\\n  - Low/intermediate risk → age-adjusted D-dimer.\\n  - High risk or positive YEARS clinical items → start therapeutic anticoagulation (e.g., enoxaparin 1 mg/kg SC q12h or IV heparin if rapid reversibility needed); obtain CTPA.\\n- Imaging:\\n  - CTPA positive → risk stratify (PESI/sPESI, RV strain on echo/CT, troponin/BNP).\\n    - High-risk (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high (RV strain + biomarkers): close monitoring; consider lysis if decompensating.\\n    - Low risk: discharge with DOAC if stable and low bleeding risk; arrange follow-up in 1 week.\\n  - V/Q if pregnant/CKD; treat with LMWH in pregnancy.\\n\\nC) Pneumothorax\\n- Small primary, minimal symptoms: oxygen, observation, repeat imaging; discharge with 24–48 h follow-up if stable.\\n- Large/symptomatic or secondary (COPD, older age): aspiration or pigtail/chest tube; admit.\\n- Recurrent or persistent air leak: thoracic surgery consult; pleurodesis/VATS.\\n\\nD) Pneumonia/pleurisy\\n- Outpatient likely (CURB-65 0–1, stable): amoxicillin 1 g TID or doxycycline 100 mg BID; if comorbidities: amoxicillin-clavulanate + doxycycline or a respiratory fluoroquinolone if necessary; add azithromycin if atypical suspected; test/tx for influenza/COVID as indicated.\\n- Inpatient (CURB-65 ≥2, hypoxia, sepsis): IV ceftriaxone + azithromycin or levofloxacin; blood cultures if severe; consider ultrasound for effusion and diagnostic tap if moderate-large.\\n- Viral pleurisy/costochondritis: NSAIDs, heat, neuropathic agents for zoster if rash (valacyclovir within 72 h).\\n\\nE) Aortic dissection red flags\\n- Severe tearing pain to back, neuro deficits, pulse/BP difference, Marfanoid habitus: BP/HR control (esmolol then vasodilator), CTA aorta; immediate cardiothoracic surgery engagement.\\n\\nDr. Alvarez (debate): I’d urge that even in pleuritic-sounding pain, the first ECG can be falsely reassuring. Repeat ECGs and troponin deltas matter, especially in women and diabetics with atypical pain. If troponin rises without classic ECG, I want an echo before anticoagulating for PE to avoid worsening an occult large pericardial effusion or aortic dissection.\\n\\nDr. Rahman (counterpoint): Agreed on echo before anticoagulation if dissection or tamponade signs exist. But for classic PE features with high pretest and no dissection signs, delays harm—initiate anticoagulation early. Use bedside echo to exclude major effusion and look for RV strain while you’re drawing labs.\\n\\nDr. Chen (moderation): We’ll do a focused echo early in anyone with shock, syncope, or chest pain with hypotension. In stable patients, I’ll let pretest guide D-dimer vs imaging; no blanket CTs.\\n\\nSpecial populations and nuances:\\n- Pregnancy/postpartum: Use pregnancy-adapted YEARS for PE; prefer V/Q; anticoagulate with LMWH. Avoid NSAIDs in 3rd trimester; pericarditis: colchicine now considered acceptable in pregnancy on a case-by-case basis with OB input.\\n- Renal impairment: Avoid contrast loads; V/Q scan or limited ultrasound approach; dose-adjust anticoagulants/colchicine.\\n- Elderly: Use age-adjusted D-dimer; higher pneumonias with atypical presentations; cautious fluid use.\\n- Young, tall, smoker/vaper: higher primary spontaneous pneumothorax risk.\\n- Cancer/estrogen therapy: higher PE risk, lower threshold for imaging and anticoagulation.\\n\\nWhat we still need from you (answer if possible):\\n- Exact age, pregnancy status, medications (OCPs/anticoagulants), smoking/vaping, recent flights/surgery, leg symptoms, fever/cough, trauma, and whether pain improves leaning forward.\\n- Current vitals and oxygen saturation.\\n\\nConsensus plan (best way forward):\\n- Immediate ECG, vitals, CXR, POCUS (lung and limited echo) for all.\\n- Apply PE pretest tools properly (PERC/Wells/YEARS) to avoid unnecessary CT; use age-adjusted D-dimer when appropriate.\\n- Use hs-troponin 0/1-hour with repeat ECG to safely exclude ACS; if discordant, get echo and tailor CT (coronary vs pulmonary vs aortic) to the dominant suspicion.\\n- Treat immediately when high probability and delay is dangerous: decompress tension pneumothorax, anticoagulate likely PE after excluding dissection/tamponade on echo, activate cath for STEMI, start antibiotics for suspected severe pneumonia without delay.\\n\\nIf you share a few key answers, we’ll route you down the correct branch and finalize treatment steps and prescriptions or admission level.\\n\\nThank you!', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 4253, 'prompt_tokens': 494, 'total_tokens': 4747, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 1536, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 0}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci25z7fQ8j0wMUlDS5isGFVyZfhOz', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, id='run--211ee895-a3f0-471f-8856-a310727899d1-0', usage_metadata={'input_tokens': 494, 'output_tokens': 4253, 'total_tokens': 4747, 'input_token_details': {'audio': 0, 'cache_read': 0}, 'output_token_details': {'audio': 0, 'reasoning': 1536}}), AIMessage(content='Final Treatment Plan for Acute Pleuritic Chest Pain\\n\\nPrimary diagnosis/differential (prioritized by immediate threat and likelihood)\\n- High-priority life-threatening causes to exclude rapidly:\\n  - Pulmonary embolism (PE)\\n  - Pneumothorax (including tension)\\n  - Acute coronary syndrome (ACS) including atypical presentations\\n  - Acute pericarditis/myopericarditis with or without effusion/tamponade\\n  - Aortic dissection\\n  - Pneumonia with/without parapneumonic effusion/empyema\\n- Lower-risk but common causes after exclusion of above:\\n  - Viral pleurisy\\n  - Costochondritis/musculoskeletal pain\\n  - Herpes zoster (early, pre-rash)\\n\\nImmediate stabilization and ED-first steps (first 10–15 minutes)\\n- Continuous monitoring: vitals, pulse oximetry, cardiac monitor; IV access.\\n- Oxygen to keep SpO2 ≥94% (or 88–92% in COPD exacerbation).\\n- 12-lead ECG immediately; repeat at 1 hour if symptoms persist/change.\\n- High-sensitivity troponin at 0 and 1 hour (0/1-hour algorithm).\\n- Point-of-care ultrasound (POCUS):\\n  - Lung: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n  - Cardiac: pericardial effusion/tamponade, RV dilation/strain, gross LV function.\\n  - Focused DVT scan (proximal femoral/popiteal) if PE suspected.\\n- Chest X-ray early (pneumothorax, consolidation, pleural effusion, mediastinal width).\\n- If unstable (shock, severe hypoxemia, altered mental status): prioritize airway/oxygenation, fluids/pressors as indicated; act on POCUS findings immediately (e.g., decompression for tension pneumothorax, pericardiocentesis for tamponade).\\n\\nDiagnostic workup with justification and decision thresholds\\n- Pulmonary embolism risk stratification:\\n  - Apply PERC if clinical suspicion is low. If PERC negative, no D-dimer or imaging.\\n  - If low/intermediate pretest probability (Wells/YEARS), order age-adjusted D-dimer (age×10 ng/mL FEU for ≥50 years). Negative rules out PE without imaging.\\n  - If high pretest probability or YEARS positive, proceed to imaging; if no signs of dissection/tamponade on POCUS and no major bleeding risk, start anticoagulation while arranging imaging.\\n  - Imaging: CT pulmonary angiography (CTPA) is first-line. Use V/Q scan if pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n  - Labs supporting risk: troponin/BNP for RV strain (risk stratification, not diagnosis).\\n- Pneumothorax:\\n  - Diagnose with POCUS (absent lung sliding/barcode sign) or upright CXR. CT only if equivocal.\\n- ACS/pericarditis:\\n  - Serial ECGs and hs-troponins; bedside echo for regional wall motion abnormalities (ACS) or pericardial effusion.\\n  - Pericarditis ECG features and positional pain support diagnosis; echo assesses effusion/tamponade.\\n- Aortic dissection:\\n  - If tearing pain, pulse/BP differential, focal neurologic deficits, new diastolic murmur, or mediastinal widening: emergent CTA aorta with contrast. Initiate beta-blockade before vasodilator if hypertensive.\\n- Pneumonia/pleurisy:\\n  - Clinical exam plus CXR. Consider COVID/flu testing in season. Procalcitonin can support but should not delay antibiotics if sepsis suspected.\\n- Baseline labs:\\n  - CBC, BMP (renal function guides contrast/anticoagulant dosing), pregnancy test where applicable; lactate if ill; blood cultures only if febrile/septic.\\n\\nInitial treatment pathways (choose based on confirmed/suspected diagnosis)\\n- Pulmonary embolism:\\n  - Start anticoagulation if high suspicion and no dissection/tamponade signs on POCUS:\\n    - DOAC option (outpatient-capable, low-risk PE): apixaban 10 mg BID for 7 days, then 5 mg BID; or rivaroxaban 15 mg BID for 21 days, then 20 mg daily. Avoid in pregnancy, severe renal impairment, or extremes of body weight with concern for underdosing.\\n    - Inpatient/hemodynamically tenuous or need rapid reversal: IV unfractionated heparin; or enoxaparin 1 mg/kg SC q12h (or q24h if CrCl <30 mL/min).\\n    - Pregnancy: LMWH (e.g., enoxaparin 1 mg/kg SC q12h); avoid DOACs and warfarin in pregnancy.\\n  - Risk-stratify:\\n    - Massive (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high (RV strain plus positive biomarkers): admit with telemetry; consider advanced therapy if decompensating.\\n    - Low risk (PESI/sPESI low, no RV strain, stable): consider ED discharge with DOAC, bleeding risk assessment, and close follow-up within 1 week.\\n- Pneumothorax:\\n  - Tension physiology: immediate needle decompression then chest tube.\\n  - Primary spontaneous, small and minimally symptomatic: supplemental oxygen, observation with repeat imaging in 4–6 hours; consider discharge if stable and reliable follow-up in 24–48 hours.\\n  - Large or symptomatic, or secondary (COPD, older): needle aspiration or pigtail/chest tube; admit. Thoracic surgery for persistent air leak or recurrence.\\n- ACS:\\n  - STEMI: activate cath lab; aspirin 325 mg chewed, P2Y12 loading, anticoagulation, high-intensity statin; nitrates and analgesia as appropriate.\\n  - NSTEMI/high-risk: anticoagulation, anti-ischemic therapy, risk-stratified early invasive approach.\\n- Pericarditis (no tamponade; myocarditis excluded or mild):\\n  - NSAID: ibuprofen 600–800 mg TID (or indomethacin 25–50 mg TID) until pain-free, then taper over 2–3 weeks.\\n  - Colchicine 0.5–0.6 mg BID (0.5–0.6 mg daily if <70 kg or intolerance) for 3 months.\\n  - Gastroprotection (PPI) if GI risk; avoid anticoagulation unless concurrent VTE.\\n  - Admit if high-risk features: fever >38°C, large effusion, troponin rise, immunosuppression, trauma, anticoagulated, or failure of NSAIDs.\\n  - Tamponade: urgent pericardiocentesis.\\n- Pneumonia:\\n  - Outpatient, low severity (CURB-65 0–1, stable): \\n    - No comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID; consider azithromycin if low macrolide resistance and QT safe.\\n    - With comorbidities: amoxicillin-clavulanate plus doxycycline or azithromycin; or monotherapy with a respiratory fluoroquinolone if needed.\\n  - Inpatient, non-severe: ceftriaxone plus azithromycin, or levofloxacin.\\n  - Suspected effusion/empyema: ultrasound-guided thoracentesis if moderate-large or clinical deterioration.\\n  - Add antivirals if influenza/COVID positive per local protocol.\\n- Viral pleurisy/costochondritis:\\n  - NSAIDs/acetaminophen, topical lidocaine patches, heat/ice, gentle mobility; avoid opioids.\\n  - If zoster suspected: valacyclovir 1 g TID for 7 days within 72 hours of rash onset.\\n- Analgesia and supportive care across conditions:\\n  - Titrate pain control to facilitate deep breathing and mobility; incentive spirometry if splinting from pain.\\n  - VTE prophylaxis if admitted and not therapeutically anticoagulated.\\n\\nDisposition and follow-up\\n- Discharge criteria:\\n  - Life-threatening causes excluded or adequately treated; vitals stable; pain controlled; oxygenation adequate on room air or home oxygen baseline; reliable follow-up.\\n- Follow-up by diagnosis:\\n  - PE (low risk, discharged on DOAC): outpatient follow-up within 1 week (primary care or thrombosis/hematology). Anticoagulation minimum 3 months; longer if unprovoked or ongoing risk. Arrange age-appropriate cancer screening if unprovoked. Educate on bleeding precautions and drug interactions.\\n  - Pneumonia (outpatient): recheck in 48–72 hours or sooner if worse. Repeat CXR at 6 weeks if age >50, smoker, or persistent symptoms to ensure resolution and exclude occult malignancy.\\n  - Pericarditis: cardiology follow-up in 1 week; exercise restriction until symptom and CRP normalization; gradual NSAID taper; colchicine adherence.\\n  - Pneumothorax: repeat CXR in 24–48 hours if outpatient; smoking/vaping cessation counseling; refer to thoracic surgery for recurrent episodes.\\n  - Musculoskeletal/viral pleurisy: primary care follow-up in 1 week; return earlier if worsening.\\n- Special populations:\\n  - Pregnancy/postpartum: use pregnancy-adapted PE algorithms; prefer V/Q scan; LMWH for anticoagulation; avoid NSAIDs in 3rd trimester; coordinate with obstetrics.\\n  - CKD: minimize contrast; dose-adjust anticoagulants/colchicine.\\n\\nRed flags requiring immediate reassessment or escalation\\n- Worsening shortness of breath, new hypoxia (SpO2 <92% on room air), cyanosis.\\n- Syncope, presyncope, or new chest pain severity/character change (especially tearing pain to back).\\n- Hemodynamic instability: SBP <90 mmHg, HR >120 with symptoms.\\n- Hemoptysis; new unilateral leg swelling/pain.\\n- Fever >38.5°C persisting beyond 72 hours of antibiotics or signs of sepsis (confusion, hypotension, oliguria).\\n- New neurologic deficits or focal weakness.\\n- Signs of tamponade: worsening dyspnea, hypotension, JVD, muffled heart sounds.\\n- Bleeding complications on anticoagulation: melena, hematemesis, significant bruising, severe headache or neurologic changes.\\n\\nKey safety notes\\n- Before initiating anticoagulation for suspected PE, screen for dissection/tamponade via clinical exam and POCUS; if dissection suspected, avoid anticoagulation until ruled out.\\n- Use age-adjusted D-dimer and PERC appropriately to avoid unnecessary CT imaging.\\n- Use shared decision-making for outpatient management of low-risk PE and small pneumothorax; ensure access to follow-up and clear return precautions.\\n\\nFinal plan complete.', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 3541, 'prompt_tokens': 2891, 'total_tokens': 6432, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 1216, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 0}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci28khQWxm10gcs2t4toGpWwDUnGC', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, name='treatment_plan', id='run--aef9fe6c-2f3e-43d5-bfa1-cbb3cc8db746-0', usage_metadata={'input_tokens': 2891, 'output_tokens': 3541, 'total_tokens': 6432, 'input_token_details': {'audio': 0, 'cache_read': 0}, 'output_token_details': {'audio': 0, 'reasoning': 1216}}), AIMessage(content='Hi, I’m Dr. Michael Chen, Emergency Medicine. Pleuritic chest pain means I must first rule out the killers that present with sharp pain worse with breathing/coughing: pulmonary embolism (PE), pneumothorax, pneumonia with sepsis, pericarditis/tamponade, ACS that masquerades, and aortic dissection. I’ll run an ED-first pathway that’s fast and structured.\\n\\nMy first 10 minutes in any age/sex:\\n- Triage and monitor: vitals, pulse ox, ECG immediately, IV access, pain score.\\n- POCUS at bedside:\\n  - Lungs: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n  - Cardiac: pericardial effusion/tamponade, RV strain (RV/LV >1, septal flattening), gross LV function.\\n  - IVC size/collapsibility; 2-point DVT scan if PE suspected.\\n- CXR early for pneumothorax, consolidation, effusion, mediastinal width.\\n- Labs: high-sensitivity troponin 0/1-hour, CBC/BMP, age-adjusted D-dimer only if indicated, pregnancy test when applicable.\\n\\nTargeted questions for you (answer if you can; if not, we’ll plan for all branches):\\n- Onset and triggers: sudden vs gradual? After cough strain, flight, surgery, immobilization, or trauma?\\n- Features: worse with inspiration/cough? Pain improve leaning forward? Any tearing pain to back?\\n- Associated symptoms: dyspnea, syncope, hemoptysis, fever/chills, productive cough, wheeze, rash.\\n- VTE risks: calf pain/swelling, prior DVT/PE, cancer, pregnancy/postpartum, OCP/estrogen, smoker/vaper.\\n- Cardiac risks: age >50, diabetes, HTN, hyperlipidemia, known CAD, cocaine use.\\n- History: asthma/COPD, prior pneumothorax, recent viral illness, connective tissue disease.\\n\\nDr. Sofia Alvarez, Cardiologist: I’m Dr. Alvarez. My lens: pleuritic pain can still be cardiac.\\n- ACS: Do not dismiss because pain is pleuritic. Serial ECGs (baseline and at 30–60 minutes) and hs-troponin deltas (0/1-hour algorithm) are critical, especially in women, elderly, and diabetics who present atypically. Regional wall motion abnormality on echo clinches ischemia even if ECG is nondiagnostic.\\n- Pericarditis/myopericarditis:\\n  - Clues: pain worse supine, better leaning forward; friction rub; diffuse concave ST elevation with PR depression; reciprocal PR elevation/ST depression in aVR.\\n  - Echo: effusion; tamponade physiology (RA/RV diastolic collapse, plethoric IVC).\\n  - Management: ibuprofen 600–800 mg TID plus colchicine 0.5–0.6 mg BID (daily if <70 kg) for 3 months; PPI; admit if fever >38°C, large effusion, troponin rise, anticoagulated, immunosuppressed, trauma, or NSAID failure. Avoid anticoagulation unless clear concurrent VTE.\\n- Aortic dissection masquerade:\\n  - Red flags: tearing pain radiating to back, pulse/BP differential, neuro deficits, new diastolic murmur. If present, control BP/HR (esmolol before vasodilator) and get CTA aorta. Anticoagulation is harmful here.\\n- I’ll push for a quick bedside echo before starting anticoagulation when there’s any suggestion of pericardial disease or dissection. If ACS suspicion persists but troponins negative and ECG nonischemic after 3 hours, CT coronary angiography can definitively exclude obstructive CAD—unless PE suspicion is higher, in which case CTPA takes priority.\\n\\nDr. Aisha Rahman, Pulmonologist: I’m Dr. Rahman. Pleuritic pain is pulmonary until proven otherwise.\\n- PE strategy:\\n  - Use pretest tools first, not D-dimer shotgun.\\n  - PERC for low suspicion: if all 8 negative (age <50, HR <100, SaO2 ≥95%, no hemoptysis, no estrogen, no prior VTE, no recent surgery/trauma, no unilateral leg swelling), skip D-dimer and imaging.\\n  - Wells/Geneva or YEARS if suspicion persists:\\n    - Wells likely (>4) or YEARS positive → proceed to imaging; if imaging delayed and no dissection/tamponade signs, start anticoagulation.\\n    - Low/intermediate → age-adjusted D-dimer (age×10 ng/mL FEU if ≥50). Negative rules out PE.\\n  - YEARS thresholds: if no YEARS items, D-dimer <1000 ng/mL rules out; if ≥1 item, <500 ng/mL rules out.\\n  - Imaging: CTPA first-line; V/Q scan preferred in pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n  - Echo markers of strain (RV/LV >1, TAPSE <17 mm, septal D-shape) support risk but don’t diagnose PE.\\n- Pneumothorax:\\n  - Risks: tall/thin young smoker/vaper, COPD/asthma, connective tissue disorders, recent procedures/ventilation.\\n  - POCUS: absent lung sliding with barcode/stratosphere sign; lung point confirms. Treat tension immediately without waiting.\\n- Pneumonia/pleurisy:\\n  - Fever, productive cough, pleural rub, focal crackles; CXR consolidation/effusion. Ultrasound for pleural fluid; tap if moderate-large or deteriorating to exclude empyema. Start antibiotics promptly if septic; don’t wait for procalcitonin.\\n\\nDebate, point-counterpoint:\\n- Dr. Alvarez: Troponin elevations occur in PE; context and echo matter. Starting anticoagulation blind could worsen an unrecognized hemopericardium or aortic dissection. I want a 2-minute focused echo first in moderate-high suspicion cases before heparin.\\n- Dr. Rahman: Agreed for shock or when dissection/tamponade features exist. But in a classic PE scenario (pleuritic pain, tachycardia, hypoxia, risk factors, clear lungs on CXR, no tearing pain, no JVD/muffled sounds), delays in anticoagulation increase harm. A quick POCUS for effusion is reasonable, but don’t defer treatment waiting on comprehensive studies.\\n- Dr. Chen: I’ll split the difference: quick POCUS on everyone with concerning vitals; if no effusion/dissection signs, we can safely anticoagulate high-probability PE while arranging CTPA. Meanwhile we keep serial ECG/hs-troponin running to avoid missing ACS.\\n\\nWhere we need your answers to choose a branch:\\n- Age and pregnancy/postpartum status.\\n- Vitals right now (HR, BP, RR, SpO2, temperature).\\n- Any cough/fever/sputum, leg swelling/pain, hemoptysis, recent flight/surgery/immobilization, estrogen use, cancer.\\n- Pain modifiers: better leaning forward? reproducible with palpation? tearing to the back?\\n- Smoking/vaping or known lung disease; prior pneumothorax.\\n\\nProvisional pathways based solely on symptom pattern (since details may be unknown):\\n- Sudden pleuritic pain with dyspnea, tachycardia, hypoxia ± hemoptysis or unilateral leg swelling: treat as likely PE.\\n  - Action now: POCUS to exclude tamponade/tension; if clear, start anticoagulation (e.g., enoxaparin 1 mg/kg SC q12h or IV heparin if possible need for reversal) and obtain CTPA; pregnancy → LMWH and V/Q scan if CXR normal.\\n- Sudden pleuritic pain after cough/strain in a young thin smoker/vaper with unilateral decreased breath sounds: likely primary pneumothorax.\\n  - Action: POCUS/CXR; if tension physiology, immediate needle decompression then chest tube. Small, stable → oxygen, observe 4–6 hours, repeat film.\\n- Pleuritic pain with fever, productive cough, focal crackles/egophony: likely pneumonia ± pleurisy.\\n  - Action: CXR; start antibiotics (outpatient: amoxicillin 1 g TID or doxycycline 100 mg BID; with comorbidities: amox-clav plus doxy or azithro; inpatient: ceftriaxone plus azithromycin). Ultrasound if effusion suspected.\\n- Sharp chest pain worse supine, better leaning forward, recent viral illness, diffuse ST elevation/PR depression: pericarditis.\\n  - Action: NSAID plus colchicine; echo to size effusion; admit if high-risk features or large effusion.\\n- Atypical but dangerous: tearing pain to back, neuro deficits, pulse/BP differential: dissection.\\n  - Action: esmolol infusion to HR <60, SBP 100–120, emergent CTA aorta; avoid anticoagulation.\\n\\nSpecific treatment details we agree on:\\n- PE low-risk discharge pathway (if ultimately confirmed): apixaban 10 mg BID for 7 days then 5 mg BID, or rivaroxaban 15 mg BID for 21 days then 20 mg daily; avoid in pregnancy and CrCl <30 for rivaroxaban; ensure 1-week follow-up. Consider sPESI, no RV strain, good social support.\\n- Pericarditis: NSAID taper over 2–3 weeks guided by CRP; exercise restriction; colchicine adherence reduces recurrence by ~50%.\\n- Pneumothorax: primary small/stable → observe; secondary or large → aspiration/pigtail catheter; recurrence or persistent leak → thoracic surgery for VATS/pleurodesis.\\n- Pneumonia: reassess at 48–72 hours; smokers/age >50 get a 6-week follow-up CXR to ensure resolution and rule out malignancy.\\n\\nSpecial populations:\\n- Pregnancy/postpartum: higher PE risk; use pregnancy-adapted YEARS; prefer V/Q; LMWH only; avoid NSAIDs late 3rd trimester.\\n- CKD stage 4–5: avoid contrast (V/Q favored), adjust anticoagulants and colchicine.\\n- Elderly: use age-adjusted D-dimer; higher pneumonia prevalence and atypical presentations.\\n\\nOur current consensus approach (best way):\\n- For any pleuritic chest pain, simultaneously obtain ECG, CXR, and POCUS. This triad within minutes directs safe next steps.\\n- Use pretest probability tools correctly (PERC/Wells/YEARS) to control D-dimer and CT overuse.\\n- Start immediate, diagnosis-directed therapy when probability is high and delay is dangerous, after a quick POCUS rules out dissection/tamponade/tension physiology.\\n\\nPlease share the answers to the targeted questions so we can finalize the exact imaging and medications today. If you can’t, we’ll default to the pathway that matches the most dangerous likely diagnosis based on your most prominent features.\\n\\nThank you!', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 3519, 'prompt_tokens': 5533, 'total_tokens': 9052, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 1152, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 0}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci2Bg0OXX5TON8mVELrZx3sFPAnZ7', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, id='run--78c6d232-7417-4556-8ff5-6f17bdfd6c63-0', usage_metadata={'input_tokens': 5533, 'output_tokens': 3519, 'total_tokens': 9052, 'input_token_details': {'audio': 0, 'cache_read': 0}, 'output_token_details': {'audio': 0, 'reasoning': 1152}}), AIMessage(content='Final Medical Treatment Plan: Acute Pleuritic Chest Pain\\n\\nPrimary diagnosis or differential (prioritized by threat and likelihood)\\n- Immediate life threats to exclude:\\n  - Pulmonary embolism (PE)\\n  - Pneumothorax (including tension)\\n  - Acute coronary syndrome (ACS) and myopericarditis\\n  - Acute pericarditis with/without tamponade\\n  - Aortic dissection\\n  - Pneumonia ± parapneumonic effusion/empyema\\n- After exclusion of above:\\n  - Viral pleurisy\\n  - Costochondritis/musculoskeletal pain\\n  - Early herpes zoster\\n\\nRecommended diagnostic tests with justification\\n- Initial (for all patients on arrival):\\n  - Continuous monitoring, pulse oximetry, IV access, pain assessment.\\n  - 12-lead ECG now and repeat at 1 hour if symptoms persist: screens for ACS/pericarditis and right heart strain.\\n  - High-sensitivity troponin at 0 and 1 hour: rules in/out myocardial injury; delta change guides ACS vs non-ACS etiologies.\\n  - Chest X-ray: detects pneumothorax, consolidation, effusion, and mediastinal widening.\\n  - Point-of-care ultrasound (POCUS):\\n    - Lung: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n    - Cardiac: pericardial effusion/tamponade, RV dilation/strain, gross LV function.\\n    - Focused lower-extremity DVT scan if PE suspected.\\n  - Labs: CBC, BMP (renal function for contrast/anticoagulant dosing), pregnancy test when applicable; lactate if ill; viral testing (COVID/flu) in season.\\n- PE risk stratification and testing:\\n  - Establish pretest probability:\\n    - Low suspicion: apply PERC. If all criteria negative, no D-dimer or imaging.\\n    - Low/intermediate probability: age-adjusted D-dimer (age×10 ng/mL FEU if ≥50). Negative rules out PE.\\n    - High probability or YEARS-positive: proceed directly to imaging. If imaging delayed and no signs of dissection/tamponade on POCUS, start anticoagulation.\\n  - Imaging: CT pulmonary angiography (CTPA). Use V/Q scan if pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n- Pneumothorax:\\n  - POCUS (absent lung sliding/barcode sign) and CXR upright if stable. CT only if equivocal.\\n- Pericarditis/myopericarditis:\\n  - ECG features (diffuse concave ST elevation, PR depression) and positional pain. Echocardiogram for effusion/tamponade.\\n  - CRP may support diagnosis and guide NSAID taper.\\n- Aortic dissection:\\n  - If tearing pain radiating to back, pulse/BP differential, neuro deficits, or widened mediastinum: emergent CTA aorta with contrast. Start beta-blocker before vasodilator.\\n- Pneumonia:\\n  - CXR for consolidation/effusion. Bedside ultrasound if effusion suspected; diagnostic thoracentesis if moderate-large or deteriorating. Consider procalcitonin as adjunct (do not delay antibiotics if septic).\\n\\nInitial treatment (condition-directed)\\n- General supportive measures:\\n  - Oxygen to maintain SpO2 ≥94% (88–92% in chronic hypercapnia).\\n  - Analgesia: acetaminophen/NSAIDs first-line; avoid opioids where possible. Incentive spirometry if splinting.\\n- Pulmonary embolism:\\n  - Start anticoagulation if high clinical probability and no dissection/tamponade signs on POCUS:\\n    - Hemodynamically stable, outpatient-eligible: apixaban 10 mg BID ×7 days then 5 mg BID; or rivaroxaban 15 mg BID ×21 days then 20 mg daily. Avoid in pregnancy or severe renal impairment.\\n    - Inpatient/tenuous or need rapid reversibility: IV unfractionated heparin; or enoxaparin 1 mg/kg SC q12h (q24h if CrCl <30 mL/min).\\n    - Pregnancy: LMWH (e.g., enoxaparin 1 mg/kg SC q12h); avoid DOACs/warfarin.\\n  - Risk-based escalation:\\n    - Massive PE (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high risk (RV strain + biomarkers): admit with telemetry; consider advanced therapy if decompensating.\\n- Pneumothorax:\\n  - Tension physiology: immediate needle decompression, then chest tube.\\n  - Small, primary, minimally symptomatic: oxygen, observe with repeat imaging in 4–6 hours; discharge with 24–48 h follow-up if stable.\\n  - Large/symptomatic or secondary (e.g., COPD): needle aspiration or pigtail/chest tube; admit. Thoracic surgery if persistent leak/recurrent episodes.\\n- ACS:\\n  - STEMI: activate cath lab; aspirin 325 mg chewed, P2Y12 loading, parenteral anticoagulation, high-intensity statin; nitrates/analgesia as appropriate.\\n  - NSTEMI/unstable angina: guideline-directed medical therapy and early invasive strategy per risk.\\n- Pericarditis (no tamponade):\\n  - NSAID: ibuprofen 600–800 mg TID (or indomethacin 25–50 mg TID) until pain-free, then taper over 2–3 weeks guided by symptoms/CRP.\\n  - Colchicine 0.5–0.6 mg BID (daily if <70 kg or intolerance) for 3 months.\\n  - PPI gastroprotection if GI risk. Avoid anticoagulation unless concurrent VTE. Admit if fever >38°C, large effusion, troponin rise, immunosuppressed, trauma, anticoagulated, or NSAID failure.\\n  - Tamponade: urgent pericardiocentesis.\\n- Pneumonia:\\n  - Outpatient, low severity (CURB-65 0–1, stable):\\n    - No comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID.\\n    - With comorbidities: amoxicillin-clavulanate plus doxycycline or azithromycin; or respiratory fluoroquinolone monotherapy if needed.\\n  - Inpatient: ceftriaxone plus azithromycin, or levofloxacin. Add antivirals if influenza/COVID positive per protocol.\\n  - Empyema suspected: ultrasound-guided thoracentesis; drain if complicated.\\n- Viral pleurisy/costochondritis:\\n  - NSAIDs/acetaminophen; topical lidocaine patches; activity modification and breathing exercises.\\n  - If zoster suspected: valacyclovir 1 g TID for 7 days within 72 hours of rash onset.\\n\\nFollow-up considerations\\n- Discharge criteria: life threats excluded/treated; vitals stable; oxygenation adequate on room air (or baseline); pain controlled; reliable follow-up and understanding of return precautions.\\n- PE (low-risk outpatient): follow-up in 1 week (primary care/thrombosis); minimum anticoagulation duration 3 months; longer if unprovoked or ongoing risk. Educate on bleeding precautions and interactions. Consider age-appropriate cancer screening in unprovoked PE.\\n- Pneumonia: re-evaluate 48–72 hours; repeat CXR at 6 weeks if age >50, smoker, or persistent symptoms to ensure resolution and exclude malignancy.\\n- Pericarditis: cardiology follow-up in ~1 week; exercise restriction until symptom and CRP normalization; ensure NSAID taper and colchicine adherence.\\n- Pneumothorax: repeat CXR in 24–48 hours if outpatient; smoking/vaping cessation; thoracic surgery referral for recurrent events.\\n- Musculoskeletal/viral pleurisy: primary care follow-up in 1 week; escalate if worsening.\\n\\nRed flags and escalation scenarios (seek immediate care)\\n- Worsening dyspnea or new hypoxia (SpO2 <92% on room air).\\n- Syncope/presyncope; hemodynamic instability (SBP <90 mmHg, persistent tachycardia >120 with symptoms).\\n- Sudden tearing chest/back pain; new neurologic deficits; pulse/BP asymmetry.\\n- Hemoptysis; new unilateral leg swelling/pain.\\n- Persistent fever >38.5°C beyond 72 hours of antibiotics; signs of sepsis (confusion, hypotension, oliguria).\\n- Signs of tamponade (worsening dyspnea, hypotension, JVD, muffled heart sounds).\\n- Bleeding on anticoagulation (melena, hematemesis, severe headache, focal neurologic change).\\n\\nSafety notes and special populations\\n- Before anticoagulating suspected PE, rapidly screen with POCUS/clinical exam for dissection/tamponade; avoid anticoagulation if dissection suspected until ruled out.\\n- Use PERC and age-adjusted D-dimer to limit unnecessary imaging.\\n- Pregnancy/postpartum: use pregnancy-adapted PE algorithms; prefer V/Q scanning; LMWH anticoagulation; avoid NSAIDs late third trimester and DOACs.\\n- CKD: minimize contrast; dose-adjust anticoagulants/colchicine.\\n\\nFinal plan complete.', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 2494, 'prompt_tokens': 7580, 'total_tokens': 10074, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 512, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 2816}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci2DsyUgQLkDRLeMdf6UJ9o3gYhVl', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, name='treatment_plan', id='run--cf50a0c0-b14f-4e69-b864-42a16232e6e7-0', usage_metadata={'input_tokens': 7580, 'output_tokens': 2494, 'total_tokens': 10074, 'input_token_details': {'audio': 0, 'cache_read': 2816}, 'output_token_details': {'audio': 0, 'reasoning': 512}})]\n"
     ]
    }
   ],
   "source": [
    "# Input\n",
    "symptom=input(\"Enter symptom\")\n",
    "max_doctors=3\n",
    "doctors=[]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"5\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": symptom}\n",
    "    ],\n",
    "    \"symptom\": symptom,\n",
    "    \"max_doctors\": max_doctors,\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "final_plan = None\n",
    "final_state = None\n",
    "\n",
    "for event in final_graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    final_state = event\n",
    "\n",
    "\n",
    "print(final_state.keys())\n",
    "print(final_state['doctors'])\n",
    "print(final_state['messages'])\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "b04715d2-a963-49eb-ba57-e1584a87fe84",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter symptom I have back pain\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['symptom', 'max_doctors', 'doctors', 'max_num_turns', 'context', 'debate', 'sections', 'messages'])\n",
      "[Doctor(name='Dr. Maya Deshmukh', qualifications='MD, FAAOS; Fellowship in Spine Surgery', specialization='Orthopedist (Spine Surgeon)', experience=15, description='Board-certified orthopedic spine surgeon focusing on degenerative spine conditions, herniated discs, and spinal stenosis. Leads a multidisciplinary spine clinic and emphasizes evidence-based conservative care with minimally invasive options when needed.'), Doctor(name='Dr. Samuel Park', qualifications='MD, FAAPMR; Fellowship in Interventional Spine & Pain', specialization='Physiatrist (Physical Medicine & Rehabilitation)', experience=12, description='Board-certified physiatrist specializing in nonoperative back pain management, therapeutic exercise, EMG/NCS, and image-guided spine injections. Coordinates comprehensive rehab programs with physical therapy and ergonomics counseling.'), Doctor(name='Dr. Aisha Rahman', qualifications='MD, FRCPC; Fellowship in Inflammatory Musculoskeletal Disease', specialization='Rheumatologist', experience=14, description='Rheumatologist with expertise in inflammatory back pain and spondyloarthropathies, including axial spondyloarthritis. Utilizes musculoskeletal ultrasound for assessment and manages advanced biologic therapies within an academic medical center.')]\n",
      "[AIMessage(content='Hi, I’m Dr. Michael Chen, Emergency Medicine. Let’s tackle acute pleuritic chest pain (sharp pain worse with deep breaths/coughing/movement). I’ll orchestrate an ED-first pathway that rapidly separates life threats (PE, pneumothorax, ACS, pericarditis, aortic dissection, pneumonia with sepsis) from benign causes (costochondritis, viral pleurisy).\\n\\nInitial ED priorities (first 10 minutes):\\n- Vitals, pulse oximetry, IV access, ECG, cardiac troponin, bedside glucose if altered.\\n- Focused exam: breath sounds (asymmetry?), JVD, calf swelling/tenderness, chest wall tenderness, fever, rash (zoster), neurologic deficits, new murmur.\\n- Point-of-care ultrasound (POCUS): lung sliding (pneumothorax), B-lines vs consolidation, IVC size/collapsibility, focused echo for pericardial effusion and RV strain; 2-point DVT scan.\\n\\nQuestions to the patient (please answer if you can; if not, we’ll plan for both branches):\\n- Onset: sudden vs gradual? Any trauma or recent vigorous cough?\\n- Pleuritic? Positional relief leaning forward?\\n- Dyspnea, syncope, hemoptysis?\\n- Fever, chills, productive cough, sick contacts, recent COVID/flu?\\n- Leg swelling/pain, recent surgery/immobilization, cancer, pregnancy/postpartum, OCP/estrogen?\\n- History of asthma/COPD, prior pneumothorax, smoking/vaping, tall/thin body habitus?\\n- Cardiovascular risks: age >50, diabetes, HTN, hyperlipidemia, known CAD, cocaine use.\\n- “Tearing” pain radiating to back, neuro symptoms, pulse differences (aortic dissection clues).\\n\\nNow I’ll invite my colleagues.\\n\\nDr. Sofia Alvarez, Cardiologist: I’m Sofia Alvarez. My priority is excluding ACS, pericarditis, and aortic dissection that can masquerade as pleuritic pain.\\n- ECG: \\n  - STEMI/NSTEMI features; note that PE can cause sinus tachycardia, right heart strain (S1Q3T3, RBBB), and minor troponin rises—context matters.\\n  - Pericarditis: diffuse concave ST elevation with PR depression; reciprocal PR elevation in aVR; pain improves leaning forward; pericardial rub.\\n- Troponin: Use high-sensitivity 0/1-hour algorithm. Elevated troponin without ischemic ECG could be PE, myocarditis, demand ischemia. Delta change is key.\\n- Echo: \\n  - Regional wall motion abnormality → ischemia.\\n  - Pericardial effusion/tamponade or thickened pericardium → pericarditis/pericardial disease.\\n  - RV dilation/dysfunction (TAPSE low, septal flattening) → PE.\\n- Aortic dissection: If “ripping” pain, mediastinal widening, BP/pulse differential, neuro deficits: do not delay CTA aorta with contrast; consider bedside TTE/TEE if unstable.\\n- Chest pain unit pathway if low-intermediate ACS risk: if troponins negative and ECG non-ischemic, consider CT coronary angiography (onset >3 h, HR controlled) to definitively exclude obstructive CAD. Avoid this if high PE likelihood—choose CTA pulmonary first based on clinical cues.\\n\\nI disagree with overusing D-dimer in older patients without pre-test stratification; indiscriminate testing inflates CT scans. Establish ACS risk and PE pretest before labs guide you.\\n\\nDr. Aisha Rahman, Pulmonologist: I’m Aisha Rahman. Pleuritic pain is pulmonary until proven otherwise: PE, pneumonia, pneumothorax, and pleurisy.\\n- Pretest assessment for PE:\\n  - If no red flags and PE seems unlikely, apply PERC (age <50, HR <100, SaO2 ≥95%, no hemoptysis, no estrogen, no prior VTE, no recent surgery/trauma, no unilateral leg swelling). If PERC negative, no D-dimer or imaging.\\n  - If low/intermediate Wells/Geneva, order age-adjusted D-dimer (age×10 ng/mL FEU for ≥50 y). If negative, PE ruled out. If positive, proceed to imaging.\\n  - If high probability by Wells (≥6) or YEARS/pregnancy-adapted YEARS positive, start anticoagulation first if no contraindications and imaging is delayed.\\n- Imaging for suspected PE:\\n  - CTA pulmonary angiography (CTPA) is first-line.\\n  - V/Q scan favored in pregnancy, severe contrast allergy, or advanced CKD; normal CXR increases V/Q utility.\\n- Pneumothorax:\\n  - Risk factors: tall/thin young, smokers/vapers, COPD/asthma, connective tissue disorders, mechanical ventilation, recent procedures.\\n  - POCUS: absent lung sliding, barcode sign; CXR upright expiratory; CT if equivocal.\\n  - Tension physiology → immediate needle decompression then chest tube.\\n- Pneumonia/pleurisy:\\n  - Fever, productive cough, pleuritic pain, focal crackles, pleural rub; CXR consolidation or effusion. Procalcitonin can support but do not delay antibiotics if septic.\\n  - Consider parapneumonic effusion/empyema: ultrasound-guided thoracentesis if moderate-large effusion or clinical deterioration.\\n\\nI’d push to avoid CT in low-risk patients using PERC/D-dimer correctly, and to use pregnancy-adapted algorithms to reduce radiation.\\n\\nDr. Chen (EM): Let’s synthesize a stepwise plan with branches based on your answers.\\n\\nStep 1: Stabilize and screen life threats\\n- If unstable (hypotension, severe hypoxia, altered): airway/oxygen, IVF/pressors as indicated, immediate POCUS.\\n  - No lung sliding + hemodynamic compromise → tension pneumothorax: needle decompression then chest tube.\\n  - Pericardial effusion with tamponade → pericardiocentesis.\\n  - Massive PE physiology (RV strain, shock) → thrombolysis/catheter-directed therapy after team huddle; fibrinolysis if crashing and no absolute contraindications.\\n\\nStep 2: Parallel ED diagnostics for stable patients\\n- ECG, serial hs-troponins (0 and 1 hour), CBC, BMP, lactate if ill, D-dimer per risk, BNP if HF suspected, viral panel during outbreaks, pregnancy test if applicable.\\n- CXR early (pneumonia, pneumothorax, effusion, mediastinal width).\\n- POCUS: lung, echo, DVT scan.\\n\\nDecision nodes:\\n\\nA) Strongly ischemic features (cardiologist’s pathway)\\n- STEMI: aspirin 325 mg chewed, P2Y12 loading, anticoagulate, statin, emergent cath.\\n- NSTEMI/high-risk: heparin, anti-ischemic therapy, risk-stratified early invasive strategy.\\n- Pericarditis: NSAIDs (e.g., ibuprofen 600–800 mg TID) + colchicine (0.5–0.6 mg BID adjusted by weight/renal), PPI protection; avoid anticoagulation unless concurrent VTE. Admit if fever >38, large effusion, troponin rise, immunosuppressed, anticoagulated, trauma, or failure of NSAIDs.\\n\\nB) Suspected PE (pulmonologist’s pathway)\\n- Pretest:\\n  - Low risk and PERC negative → no D-dimer, no imaging; consider musculoskeletal/viral pleurisy.\\n  - Low/intermediate risk → age-adjusted D-dimer.\\n  - High risk or positive YEARS clinical items → start therapeutic anticoagulation (e.g., enoxaparin 1 mg/kg SC q12h or IV heparin if rapid reversibility needed); obtain CTPA.\\n- Imaging:\\n  - CTPA positive → risk stratify (PESI/sPESI, RV strain on echo/CT, troponin/BNP).\\n    - High-risk (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high (RV strain + biomarkers): close monitoring; consider lysis if decompensating.\\n    - Low risk: discharge with DOAC if stable and low bleeding risk; arrange follow-up in 1 week.\\n  - V/Q if pregnant/CKD; treat with LMWH in pregnancy.\\n\\nC) Pneumothorax\\n- Small primary, minimal symptoms: oxygen, observation, repeat imaging; discharge with 24–48 h follow-up if stable.\\n- Large/symptomatic or secondary (COPD, older age): aspiration or pigtail/chest tube; admit.\\n- Recurrent or persistent air leak: thoracic surgery consult; pleurodesis/VATS.\\n\\nD) Pneumonia/pleurisy\\n- Outpatient likely (CURB-65 0–1, stable): amoxicillin 1 g TID or doxycycline 100 mg BID; if comorbidities: amoxicillin-clavulanate + doxycycline or a respiratory fluoroquinolone if necessary; add azithromycin if atypical suspected; test/tx for influenza/COVID as indicated.\\n- Inpatient (CURB-65 ≥2, hypoxia, sepsis): IV ceftriaxone + azithromycin or levofloxacin; blood cultures if severe; consider ultrasound for effusion and diagnostic tap if moderate-large.\\n- Viral pleurisy/costochondritis: NSAIDs, heat, neuropathic agents for zoster if rash (valacyclovir within 72 h).\\n\\nE) Aortic dissection red flags\\n- Severe tearing pain to back, neuro deficits, pulse/BP difference, Marfanoid habitus: BP/HR control (esmolol then vasodilator), CTA aorta; immediate cardiothoracic surgery engagement.\\n\\nDr. Alvarez (debate): I’d urge that even in pleuritic-sounding pain, the first ECG can be falsely reassuring. Repeat ECGs and troponin deltas matter, especially in women and diabetics with atypical pain. If troponin rises without classic ECG, I want an echo before anticoagulating for PE to avoid worsening an occult large pericardial effusion or aortic dissection.\\n\\nDr. Rahman (counterpoint): Agreed on echo before anticoagulation if dissection or tamponade signs exist. But for classic PE features with high pretest and no dissection signs, delays harm—initiate anticoagulation early. Use bedside echo to exclude major effusion and look for RV strain while you’re drawing labs.\\n\\nDr. Chen (moderation): We’ll do a focused echo early in anyone with shock, syncope, or chest pain with hypotension. In stable patients, I’ll let pretest guide D-dimer vs imaging; no blanket CTs.\\n\\nSpecial populations and nuances:\\n- Pregnancy/postpartum: Use pregnancy-adapted YEARS for PE; prefer V/Q; anticoagulate with LMWH. Avoid NSAIDs in 3rd trimester; pericarditis: colchicine now considered acceptable in pregnancy on a case-by-case basis with OB input.\\n- Renal impairment: Avoid contrast loads; V/Q scan or limited ultrasound approach; dose-adjust anticoagulants/colchicine.\\n- Elderly: Use age-adjusted D-dimer; higher pneumonias with atypical presentations; cautious fluid use.\\n- Young, tall, smoker/vaper: higher primary spontaneous pneumothorax risk.\\n- Cancer/estrogen therapy: higher PE risk, lower threshold for imaging and anticoagulation.\\n\\nWhat we still need from you (answer if possible):\\n- Exact age, pregnancy status, medications (OCPs/anticoagulants), smoking/vaping, recent flights/surgery, leg symptoms, fever/cough, trauma, and whether pain improves leaning forward.\\n- Current vitals and oxygen saturation.\\n\\nConsensus plan (best way forward):\\n- Immediate ECG, vitals, CXR, POCUS (lung and limited echo) for all.\\n- Apply PE pretest tools properly (PERC/Wells/YEARS) to avoid unnecessary CT; use age-adjusted D-dimer when appropriate.\\n- Use hs-troponin 0/1-hour with repeat ECG to safely exclude ACS; if discordant, get echo and tailor CT (coronary vs pulmonary vs aortic) to the dominant suspicion.\\n- Treat immediately when high probability and delay is dangerous: decompress tension pneumothorax, anticoagulate likely PE after excluding dissection/tamponade on echo, activate cath for STEMI, start antibiotics for suspected severe pneumonia without delay.\\n\\nIf you share a few key answers, we’ll route you down the correct branch and finalize treatment steps and prescriptions or admission level.\\n\\nThank you!', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 4253, 'prompt_tokens': 494, 'total_tokens': 4747, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 1536, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 0}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci25z7fQ8j0wMUlDS5isGFVyZfhOz', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, id='run--211ee895-a3f0-471f-8856-a310727899d1-0', usage_metadata={'input_tokens': 494, 'output_tokens': 4253, 'total_tokens': 4747, 'input_token_details': {'audio': 0, 'cache_read': 0}, 'output_token_details': {'audio': 0, 'reasoning': 1536}}), AIMessage(content='Final Treatment Plan for Acute Pleuritic Chest Pain\\n\\nPrimary diagnosis/differential (prioritized by immediate threat and likelihood)\\n- High-priority life-threatening causes to exclude rapidly:\\n  - Pulmonary embolism (PE)\\n  - Pneumothorax (including tension)\\n  - Acute coronary syndrome (ACS) including atypical presentations\\n  - Acute pericarditis/myopericarditis with or without effusion/tamponade\\n  - Aortic dissection\\n  - Pneumonia with/without parapneumonic effusion/empyema\\n- Lower-risk but common causes after exclusion of above:\\n  - Viral pleurisy\\n  - Costochondritis/musculoskeletal pain\\n  - Herpes zoster (early, pre-rash)\\n\\nImmediate stabilization and ED-first steps (first 10–15 minutes)\\n- Continuous monitoring: vitals, pulse oximetry, cardiac monitor; IV access.\\n- Oxygen to keep SpO2 ≥94% (or 88–92% in COPD exacerbation).\\n- 12-lead ECG immediately; repeat at 1 hour if symptoms persist/change.\\n- High-sensitivity troponin at 0 and 1 hour (0/1-hour algorithm).\\n- Point-of-care ultrasound (POCUS):\\n  - Lung: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n  - Cardiac: pericardial effusion/tamponade, RV dilation/strain, gross LV function.\\n  - Focused DVT scan (proximal femoral/popiteal) if PE suspected.\\n- Chest X-ray early (pneumothorax, consolidation, pleural effusion, mediastinal width).\\n- If unstable (shock, severe hypoxemia, altered mental status): prioritize airway/oxygenation, fluids/pressors as indicated; act on POCUS findings immediately (e.g., decompression for tension pneumothorax, pericardiocentesis for tamponade).\\n\\nDiagnostic workup with justification and decision thresholds\\n- Pulmonary embolism risk stratification:\\n  - Apply PERC if clinical suspicion is low. If PERC negative, no D-dimer or imaging.\\n  - If low/intermediate pretest probability (Wells/YEARS), order age-adjusted D-dimer (age×10 ng/mL FEU for ≥50 years). Negative rules out PE without imaging.\\n  - If high pretest probability or YEARS positive, proceed to imaging; if no signs of dissection/tamponade on POCUS and no major bleeding risk, start anticoagulation while arranging imaging.\\n  - Imaging: CT pulmonary angiography (CTPA) is first-line. Use V/Q scan if pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n  - Labs supporting risk: troponin/BNP for RV strain (risk stratification, not diagnosis).\\n- Pneumothorax:\\n  - Diagnose with POCUS (absent lung sliding/barcode sign) or upright CXR. CT only if equivocal.\\n- ACS/pericarditis:\\n  - Serial ECGs and hs-troponins; bedside echo for regional wall motion abnormalities (ACS) or pericardial effusion.\\n  - Pericarditis ECG features and positional pain support diagnosis; echo assesses effusion/tamponade.\\n- Aortic dissection:\\n  - If tearing pain, pulse/BP differential, focal neurologic deficits, new diastolic murmur, or mediastinal widening: emergent CTA aorta with contrast. Initiate beta-blockade before vasodilator if hypertensive.\\n- Pneumonia/pleurisy:\\n  - Clinical exam plus CXR. Consider COVID/flu testing in season. Procalcitonin can support but should not delay antibiotics if sepsis suspected.\\n- Baseline labs:\\n  - CBC, BMP (renal function guides contrast/anticoagulant dosing), pregnancy test where applicable; lactate if ill; blood cultures only if febrile/septic.\\n\\nInitial treatment pathways (choose based on confirmed/suspected diagnosis)\\n- Pulmonary embolism:\\n  - Start anticoagulation if high suspicion and no dissection/tamponade signs on POCUS:\\n    - DOAC option (outpatient-capable, low-risk PE): apixaban 10 mg BID for 7 days, then 5 mg BID; or rivaroxaban 15 mg BID for 21 days, then 20 mg daily. Avoid in pregnancy, severe renal impairment, or extremes of body weight with concern for underdosing.\\n    - Inpatient/hemodynamically tenuous or need rapid reversal: IV unfractionated heparin; or enoxaparin 1 mg/kg SC q12h (or q24h if CrCl <30 mL/min).\\n    - Pregnancy: LMWH (e.g., enoxaparin 1 mg/kg SC q12h); avoid DOACs and warfarin in pregnancy.\\n  - Risk-stratify:\\n    - Massive (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high (RV strain plus positive biomarkers): admit with telemetry; consider advanced therapy if decompensating.\\n    - Low risk (PESI/sPESI low, no RV strain, stable): consider ED discharge with DOAC, bleeding risk assessment, and close follow-up within 1 week.\\n- Pneumothorax:\\n  - Tension physiology: immediate needle decompression then chest tube.\\n  - Primary spontaneous, small and minimally symptomatic: supplemental oxygen, observation with repeat imaging in 4–6 hours; consider discharge if stable and reliable follow-up in 24–48 hours.\\n  - Large or symptomatic, or secondary (COPD, older): needle aspiration or pigtail/chest tube; admit. Thoracic surgery for persistent air leak or recurrence.\\n- ACS:\\n  - STEMI: activate cath lab; aspirin 325 mg chewed, P2Y12 loading, anticoagulation, high-intensity statin; nitrates and analgesia as appropriate.\\n  - NSTEMI/high-risk: anticoagulation, anti-ischemic therapy, risk-stratified early invasive approach.\\n- Pericarditis (no tamponade; myocarditis excluded or mild):\\n  - NSAID: ibuprofen 600–800 mg TID (or indomethacin 25–50 mg TID) until pain-free, then taper over 2–3 weeks.\\n  - Colchicine 0.5–0.6 mg BID (0.5–0.6 mg daily if <70 kg or intolerance) for 3 months.\\n  - Gastroprotection (PPI) if GI risk; avoid anticoagulation unless concurrent VTE.\\n  - Admit if high-risk features: fever >38°C, large effusion, troponin rise, immunosuppression, trauma, anticoagulated, or failure of NSAIDs.\\n  - Tamponade: urgent pericardiocentesis.\\n- Pneumonia:\\n  - Outpatient, low severity (CURB-65 0–1, stable): \\n    - No comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID; consider azithromycin if low macrolide resistance and QT safe.\\n    - With comorbidities: amoxicillin-clavulanate plus doxycycline or azithromycin; or monotherapy with a respiratory fluoroquinolone if needed.\\n  - Inpatient, non-severe: ceftriaxone plus azithromycin, or levofloxacin.\\n  - Suspected effusion/empyema: ultrasound-guided thoracentesis if moderate-large or clinical deterioration.\\n  - Add antivirals if influenza/COVID positive per local protocol.\\n- Viral pleurisy/costochondritis:\\n  - NSAIDs/acetaminophen, topical lidocaine patches, heat/ice, gentle mobility; avoid opioids.\\n  - If zoster suspected: valacyclovir 1 g TID for 7 days within 72 hours of rash onset.\\n- Analgesia and supportive care across conditions:\\n  - Titrate pain control to facilitate deep breathing and mobility; incentive spirometry if splinting from pain.\\n  - VTE prophylaxis if admitted and not therapeutically anticoagulated.\\n\\nDisposition and follow-up\\n- Discharge criteria:\\n  - Life-threatening causes excluded or adequately treated; vitals stable; pain controlled; oxygenation adequate on room air or home oxygen baseline; reliable follow-up.\\n- Follow-up by diagnosis:\\n  - PE (low risk, discharged on DOAC): outpatient follow-up within 1 week (primary care or thrombosis/hematology). Anticoagulation minimum 3 months; longer if unprovoked or ongoing risk. Arrange age-appropriate cancer screening if unprovoked. Educate on bleeding precautions and drug interactions.\\n  - Pneumonia (outpatient): recheck in 48–72 hours or sooner if worse. Repeat CXR at 6 weeks if age >50, smoker, or persistent symptoms to ensure resolution and exclude occult malignancy.\\n  - Pericarditis: cardiology follow-up in 1 week; exercise restriction until symptom and CRP normalization; gradual NSAID taper; colchicine adherence.\\n  - Pneumothorax: repeat CXR in 24–48 hours if outpatient; smoking/vaping cessation counseling; refer to thoracic surgery for recurrent episodes.\\n  - Musculoskeletal/viral pleurisy: primary care follow-up in 1 week; return earlier if worsening.\\n- Special populations:\\n  - Pregnancy/postpartum: use pregnancy-adapted PE algorithms; prefer V/Q scan; LMWH for anticoagulation; avoid NSAIDs in 3rd trimester; coordinate with obstetrics.\\n  - CKD: minimize contrast; dose-adjust anticoagulants/colchicine.\\n\\nRed flags requiring immediate reassessment or escalation\\n- Worsening shortness of breath, new hypoxia (SpO2 <92% on room air), cyanosis.\\n- Syncope, presyncope, or new chest pain severity/character change (especially tearing pain to back).\\n- Hemodynamic instability: SBP <90 mmHg, HR >120 with symptoms.\\n- Hemoptysis; new unilateral leg swelling/pain.\\n- Fever >38.5°C persisting beyond 72 hours of antibiotics or signs of sepsis (confusion, hypotension, oliguria).\\n- New neurologic deficits or focal weakness.\\n- Signs of tamponade: worsening dyspnea, hypotension, JVD, muffled heart sounds.\\n- Bleeding complications on anticoagulation: melena, hematemesis, significant bruising, severe headache or neurologic changes.\\n\\nKey safety notes\\n- Before initiating anticoagulation for suspected PE, screen for dissection/tamponade via clinical exam and POCUS; if dissection suspected, avoid anticoagulation until ruled out.\\n- Use age-adjusted D-dimer and PERC appropriately to avoid unnecessary CT imaging.\\n- Use shared decision-making for outpatient management of low-risk PE and small pneumothorax; ensure access to follow-up and clear return precautions.\\n\\nFinal plan complete.', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 3541, 'prompt_tokens': 2891, 'total_tokens': 6432, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 1216, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 0}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci28khQWxm10gcs2t4toGpWwDUnGC', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, name='treatment_plan', id='run--aef9fe6c-2f3e-43d5-bfa1-cbb3cc8db746-0', usage_metadata={'input_tokens': 2891, 'output_tokens': 3541, 'total_tokens': 6432, 'input_token_details': {'audio': 0, 'cache_read': 0}, 'output_token_details': {'audio': 0, 'reasoning': 1216}}), AIMessage(content='Hi, I’m Dr. Michael Chen, Emergency Medicine. Pleuritic chest pain means I must first rule out the killers that present with sharp pain worse with breathing/coughing: pulmonary embolism (PE), pneumothorax, pneumonia with sepsis, pericarditis/tamponade, ACS that masquerades, and aortic dissection. I’ll run an ED-first pathway that’s fast and structured.\\n\\nMy first 10 minutes in any age/sex:\\n- Triage and monitor: vitals, pulse ox, ECG immediately, IV access, pain score.\\n- POCUS at bedside:\\n  - Lungs: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n  - Cardiac: pericardial effusion/tamponade, RV strain (RV/LV >1, septal flattening), gross LV function.\\n  - IVC size/collapsibility; 2-point DVT scan if PE suspected.\\n- CXR early for pneumothorax, consolidation, effusion, mediastinal width.\\n- Labs: high-sensitivity troponin 0/1-hour, CBC/BMP, age-adjusted D-dimer only if indicated, pregnancy test when applicable.\\n\\nTargeted questions for you (answer if you can; if not, we’ll plan for all branches):\\n- Onset and triggers: sudden vs gradual? After cough strain, flight, surgery, immobilization, or trauma?\\n- Features: worse with inspiration/cough? Pain improve leaning forward? Any tearing pain to back?\\n- Associated symptoms: dyspnea, syncope, hemoptysis, fever/chills, productive cough, wheeze, rash.\\n- VTE risks: calf pain/swelling, prior DVT/PE, cancer, pregnancy/postpartum, OCP/estrogen, smoker/vaper.\\n- Cardiac risks: age >50, diabetes, HTN, hyperlipidemia, known CAD, cocaine use.\\n- History: asthma/COPD, prior pneumothorax, recent viral illness, connective tissue disease.\\n\\nDr. Sofia Alvarez, Cardiologist: I’m Dr. Alvarez. My lens: pleuritic pain can still be cardiac.\\n- ACS: Do not dismiss because pain is pleuritic. Serial ECGs (baseline and at 30–60 minutes) and hs-troponin deltas (0/1-hour algorithm) are critical, especially in women, elderly, and diabetics who present atypically. Regional wall motion abnormality on echo clinches ischemia even if ECG is nondiagnostic.\\n- Pericarditis/myopericarditis:\\n  - Clues: pain worse supine, better leaning forward; friction rub; diffuse concave ST elevation with PR depression; reciprocal PR elevation/ST depression in aVR.\\n  - Echo: effusion; tamponade physiology (RA/RV diastolic collapse, plethoric IVC).\\n  - Management: ibuprofen 600–800 mg TID plus colchicine 0.5–0.6 mg BID (daily if <70 kg) for 3 months; PPI; admit if fever >38°C, large effusion, troponin rise, anticoagulated, immunosuppressed, trauma, or NSAID failure. Avoid anticoagulation unless clear concurrent VTE.\\n- Aortic dissection masquerade:\\n  - Red flags: tearing pain radiating to back, pulse/BP differential, neuro deficits, new diastolic murmur. If present, control BP/HR (esmolol before vasodilator) and get CTA aorta. Anticoagulation is harmful here.\\n- I’ll push for a quick bedside echo before starting anticoagulation when there’s any suggestion of pericardial disease or dissection. If ACS suspicion persists but troponins negative and ECG nonischemic after 3 hours, CT coronary angiography can definitively exclude obstructive CAD—unless PE suspicion is higher, in which case CTPA takes priority.\\n\\nDr. Aisha Rahman, Pulmonologist: I’m Dr. Rahman. Pleuritic pain is pulmonary until proven otherwise.\\n- PE strategy:\\n  - Use pretest tools first, not D-dimer shotgun.\\n  - PERC for low suspicion: if all 8 negative (age <50, HR <100, SaO2 ≥95%, no hemoptysis, no estrogen, no prior VTE, no recent surgery/trauma, no unilateral leg swelling), skip D-dimer and imaging.\\n  - Wells/Geneva or YEARS if suspicion persists:\\n    - Wells likely (>4) or YEARS positive → proceed to imaging; if imaging delayed and no dissection/tamponade signs, start anticoagulation.\\n    - Low/intermediate → age-adjusted D-dimer (age×10 ng/mL FEU if ≥50). Negative rules out PE.\\n  - YEARS thresholds: if no YEARS items, D-dimer <1000 ng/mL rules out; if ≥1 item, <500 ng/mL rules out.\\n  - Imaging: CTPA first-line; V/Q scan preferred in pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n  - Echo markers of strain (RV/LV >1, TAPSE <17 mm, septal D-shape) support risk but don’t diagnose PE.\\n- Pneumothorax:\\n  - Risks: tall/thin young smoker/vaper, COPD/asthma, connective tissue disorders, recent procedures/ventilation.\\n  - POCUS: absent lung sliding with barcode/stratosphere sign; lung point confirms. Treat tension immediately without waiting.\\n- Pneumonia/pleurisy:\\n  - Fever, productive cough, pleural rub, focal crackles; CXR consolidation/effusion. Ultrasound for pleural fluid; tap if moderate-large or deteriorating to exclude empyema. Start antibiotics promptly if septic; don’t wait for procalcitonin.\\n\\nDebate, point-counterpoint:\\n- Dr. Alvarez: Troponin elevations occur in PE; context and echo matter. Starting anticoagulation blind could worsen an unrecognized hemopericardium or aortic dissection. I want a 2-minute focused echo first in moderate-high suspicion cases before heparin.\\n- Dr. Rahman: Agreed for shock or when dissection/tamponade features exist. But in a classic PE scenario (pleuritic pain, tachycardia, hypoxia, risk factors, clear lungs on CXR, no tearing pain, no JVD/muffled sounds), delays in anticoagulation increase harm. A quick POCUS for effusion is reasonable, but don’t defer treatment waiting on comprehensive studies.\\n- Dr. Chen: I’ll split the difference: quick POCUS on everyone with concerning vitals; if no effusion/dissection signs, we can safely anticoagulate high-probability PE while arranging CTPA. Meanwhile we keep serial ECG/hs-troponin running to avoid missing ACS.\\n\\nWhere we need your answers to choose a branch:\\n- Age and pregnancy/postpartum status.\\n- Vitals right now (HR, BP, RR, SpO2, temperature).\\n- Any cough/fever/sputum, leg swelling/pain, hemoptysis, recent flight/surgery/immobilization, estrogen use, cancer.\\n- Pain modifiers: better leaning forward? reproducible with palpation? tearing to the back?\\n- Smoking/vaping or known lung disease; prior pneumothorax.\\n\\nProvisional pathways based solely on symptom pattern (since details may be unknown):\\n- Sudden pleuritic pain with dyspnea, tachycardia, hypoxia ± hemoptysis or unilateral leg swelling: treat as likely PE.\\n  - Action now: POCUS to exclude tamponade/tension; if clear, start anticoagulation (e.g., enoxaparin 1 mg/kg SC q12h or IV heparin if possible need for reversal) and obtain CTPA; pregnancy → LMWH and V/Q scan if CXR normal.\\n- Sudden pleuritic pain after cough/strain in a young thin smoker/vaper with unilateral decreased breath sounds: likely primary pneumothorax.\\n  - Action: POCUS/CXR; if tension physiology, immediate needle decompression then chest tube. Small, stable → oxygen, observe 4–6 hours, repeat film.\\n- Pleuritic pain with fever, productive cough, focal crackles/egophony: likely pneumonia ± pleurisy.\\n  - Action: CXR; start antibiotics (outpatient: amoxicillin 1 g TID or doxycycline 100 mg BID; with comorbidities: amox-clav plus doxy or azithro; inpatient: ceftriaxone plus azithromycin). Ultrasound if effusion suspected.\\n- Sharp chest pain worse supine, better leaning forward, recent viral illness, diffuse ST elevation/PR depression: pericarditis.\\n  - Action: NSAID plus colchicine; echo to size effusion; admit if high-risk features or large effusion.\\n- Atypical but dangerous: tearing pain to back, neuro deficits, pulse/BP differential: dissection.\\n  - Action: esmolol infusion to HR <60, SBP 100–120, emergent CTA aorta; avoid anticoagulation.\\n\\nSpecific treatment details we agree on:\\n- PE low-risk discharge pathway (if ultimately confirmed): apixaban 10 mg BID for 7 days then 5 mg BID, or rivaroxaban 15 mg BID for 21 days then 20 mg daily; avoid in pregnancy and CrCl <30 for rivaroxaban; ensure 1-week follow-up. Consider sPESI, no RV strain, good social support.\\n- Pericarditis: NSAID taper over 2–3 weeks guided by CRP; exercise restriction; colchicine adherence reduces recurrence by ~50%.\\n- Pneumothorax: primary small/stable → observe; secondary or large → aspiration/pigtail catheter; recurrence or persistent leak → thoracic surgery for VATS/pleurodesis.\\n- Pneumonia: reassess at 48–72 hours; smokers/age >50 get a 6-week follow-up CXR to ensure resolution and rule out malignancy.\\n\\nSpecial populations:\\n- Pregnancy/postpartum: higher PE risk; use pregnancy-adapted YEARS; prefer V/Q; LMWH only; avoid NSAIDs late 3rd trimester.\\n- CKD stage 4–5: avoid contrast (V/Q favored), adjust anticoagulants and colchicine.\\n- Elderly: use age-adjusted D-dimer; higher pneumonia prevalence and atypical presentations.\\n\\nOur current consensus approach (best way):\\n- For any pleuritic chest pain, simultaneously obtain ECG, CXR, and POCUS. This triad within minutes directs safe next steps.\\n- Use pretest probability tools correctly (PERC/Wells/YEARS) to control D-dimer and CT overuse.\\n- Start immediate, diagnosis-directed therapy when probability is high and delay is dangerous, after a quick POCUS rules out dissection/tamponade/tension physiology.\\n\\nPlease share the answers to the targeted questions so we can finalize the exact imaging and medications today. If you can’t, we’ll default to the pathway that matches the most dangerous likely diagnosis based on your most prominent features.\\n\\nThank you!', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 3519, 'prompt_tokens': 5533, 'total_tokens': 9052, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 1152, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 0}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci2Bg0OXX5TON8mVELrZx3sFPAnZ7', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, id='run--78c6d232-7417-4556-8ff5-6f17bdfd6c63-0', usage_metadata={'input_tokens': 5533, 'output_tokens': 3519, 'total_tokens': 9052, 'input_token_details': {'audio': 0, 'cache_read': 0}, 'output_token_details': {'audio': 0, 'reasoning': 1152}}), AIMessage(content='Final Medical Treatment Plan: Acute Pleuritic Chest Pain\\n\\nPrimary diagnosis or differential (prioritized by threat and likelihood)\\n- Immediate life threats to exclude:\\n  - Pulmonary embolism (PE)\\n  - Pneumothorax (including tension)\\n  - Acute coronary syndrome (ACS) and myopericarditis\\n  - Acute pericarditis with/without tamponade\\n  - Aortic dissection\\n  - Pneumonia ± parapneumonic effusion/empyema\\n- After exclusion of above:\\n  - Viral pleurisy\\n  - Costochondritis/musculoskeletal pain\\n  - Early herpes zoster\\n\\nRecommended diagnostic tests with justification\\n- Initial (for all patients on arrival):\\n  - Continuous monitoring, pulse oximetry, IV access, pain assessment.\\n  - 12-lead ECG now and repeat at 1 hour if symptoms persist: screens for ACS/pericarditis and right heart strain.\\n  - High-sensitivity troponin at 0 and 1 hour: rules in/out myocardial injury; delta change guides ACS vs non-ACS etiologies.\\n  - Chest X-ray: detects pneumothorax, consolidation, effusion, and mediastinal widening.\\n  - Point-of-care ultrasound (POCUS):\\n    - Lung: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n    - Cardiac: pericardial effusion/tamponade, RV dilation/strain, gross LV function.\\n    - Focused lower-extremity DVT scan if PE suspected.\\n  - Labs: CBC, BMP (renal function for contrast/anticoagulant dosing), pregnancy test when applicable; lactate if ill; viral testing (COVID/flu) in season.\\n- PE risk stratification and testing:\\n  - Establish pretest probability:\\n    - Low suspicion: apply PERC. If all criteria negative, no D-dimer or imaging.\\n    - Low/intermediate probability: age-adjusted D-dimer (age×10 ng/mL FEU if ≥50). Negative rules out PE.\\n    - High probability or YEARS-positive: proceed directly to imaging. If imaging delayed and no signs of dissection/tamponade on POCUS, start anticoagulation.\\n  - Imaging: CT pulmonary angiography (CTPA). Use V/Q scan if pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n- Pneumothorax:\\n  - POCUS (absent lung sliding/barcode sign) and CXR upright if stable. CT only if equivocal.\\n- Pericarditis/myopericarditis:\\n  - ECG features (diffuse concave ST elevation, PR depression) and positional pain. Echocardiogram for effusion/tamponade.\\n  - CRP may support diagnosis and guide NSAID taper.\\n- Aortic dissection:\\n  - If tearing pain radiating to back, pulse/BP differential, neuro deficits, or widened mediastinum: emergent CTA aorta with contrast. Start beta-blocker before vasodilator.\\n- Pneumonia:\\n  - CXR for consolidation/effusion. Bedside ultrasound if effusion suspected; diagnostic thoracentesis if moderate-large or deteriorating. Consider procalcitonin as adjunct (do not delay antibiotics if septic).\\n\\nInitial treatment (condition-directed)\\n- General supportive measures:\\n  - Oxygen to maintain SpO2 ≥94% (88–92% in chronic hypercapnia).\\n  - Analgesia: acetaminophen/NSAIDs first-line; avoid opioids where possible. Incentive spirometry if splinting.\\n- Pulmonary embolism:\\n  - Start anticoagulation if high clinical probability and no dissection/tamponade signs on POCUS:\\n    - Hemodynamically stable, outpatient-eligible: apixaban 10 mg BID ×7 days then 5 mg BID; or rivaroxaban 15 mg BID ×21 days then 20 mg daily. Avoid in pregnancy or severe renal impairment.\\n    - Inpatient/tenuous or need rapid reversibility: IV unfractionated heparin; or enoxaparin 1 mg/kg SC q12h (q24h if CrCl <30 mL/min).\\n    - Pregnancy: LMWH (e.g., enoxaparin 1 mg/kg SC q12h); avoid DOACs/warfarin.\\n  - Risk-based escalation:\\n    - Massive PE (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high risk (RV strain + biomarkers): admit with telemetry; consider advanced therapy if decompensating.\\n- Pneumothorax:\\n  - Tension physiology: immediate needle decompression, then chest tube.\\n  - Small, primary, minimally symptomatic: oxygen, observe with repeat imaging in 4–6 hours; discharge with 24–48 h follow-up if stable.\\n  - Large/symptomatic or secondary (e.g., COPD): needle aspiration or pigtail/chest tube; admit. Thoracic surgery if persistent leak/recurrent episodes.\\n- ACS:\\n  - STEMI: activate cath lab; aspirin 325 mg chewed, P2Y12 loading, parenteral anticoagulation, high-intensity statin; nitrates/analgesia as appropriate.\\n  - NSTEMI/unstable angina: guideline-directed medical therapy and early invasive strategy per risk.\\n- Pericarditis (no tamponade):\\n  - NSAID: ibuprofen 600–800 mg TID (or indomethacin 25–50 mg TID) until pain-free, then taper over 2–3 weeks guided by symptoms/CRP.\\n  - Colchicine 0.5–0.6 mg BID (daily if <70 kg or intolerance) for 3 months.\\n  - PPI gastroprotection if GI risk. Avoid anticoagulation unless concurrent VTE. Admit if fever >38°C, large effusion, troponin rise, immunosuppressed, trauma, anticoagulated, or NSAID failure.\\n  - Tamponade: urgent pericardiocentesis.\\n- Pneumonia:\\n  - Outpatient, low severity (CURB-65 0–1, stable):\\n    - No comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID.\\n    - With comorbidities: amoxicillin-clavulanate plus doxycycline or azithromycin; or respiratory fluoroquinolone monotherapy if needed.\\n  - Inpatient: ceftriaxone plus azithromycin, or levofloxacin. Add antivirals if influenza/COVID positive per protocol.\\n  - Empyema suspected: ultrasound-guided thoracentesis; drain if complicated.\\n- Viral pleurisy/costochondritis:\\n  - NSAIDs/acetaminophen; topical lidocaine patches; activity modification and breathing exercises.\\n  - If zoster suspected: valacyclovir 1 g TID for 7 days within 72 hours of rash onset.\\n\\nFollow-up considerations\\n- Discharge criteria: life threats excluded/treated; vitals stable; oxygenation adequate on room air (or baseline); pain controlled; reliable follow-up and understanding of return precautions.\\n- PE (low-risk outpatient): follow-up in 1 week (primary care/thrombosis); minimum anticoagulation duration 3 months; longer if unprovoked or ongoing risk. Educate on bleeding precautions and interactions. Consider age-appropriate cancer screening in unprovoked PE.\\n- Pneumonia: re-evaluate 48–72 hours; repeat CXR at 6 weeks if age >50, smoker, or persistent symptoms to ensure resolution and exclude malignancy.\\n- Pericarditis: cardiology follow-up in ~1 week; exercise restriction until symptom and CRP normalization; ensure NSAID taper and colchicine adherence.\\n- Pneumothorax: repeat CXR in 24–48 hours if outpatient; smoking/vaping cessation; thoracic surgery referral for recurrent events.\\n- Musculoskeletal/viral pleurisy: primary care follow-up in 1 week; escalate if worsening.\\n\\nRed flags and escalation scenarios (seek immediate care)\\n- Worsening dyspnea or new hypoxia (SpO2 <92% on room air).\\n- Syncope/presyncope; hemodynamic instability (SBP <90 mmHg, persistent tachycardia >120 with symptoms).\\n- Sudden tearing chest/back pain; new neurologic deficits; pulse/BP asymmetry.\\n- Hemoptysis; new unilateral leg swelling/pain.\\n- Persistent fever >38.5°C beyond 72 hours of antibiotics; signs of sepsis (confusion, hypotension, oliguria).\\n- Signs of tamponade (worsening dyspnea, hypotension, JVD, muffled heart sounds).\\n- Bleeding on anticoagulation (melena, hematemesis, severe headache, focal neurologic change).\\n\\nSafety notes and special populations\\n- Before anticoagulating suspected PE, rapidly screen with POCUS/clinical exam for dissection/tamponade; avoid anticoagulation if dissection suspected until ruled out.\\n- Use PERC and age-adjusted D-dimer to limit unnecessary imaging.\\n- Pregnancy/postpartum: use pregnancy-adapted PE algorithms; prefer V/Q scanning; LMWH anticoagulation; avoid NSAIDs late third trimester and DOACs.\\n- CKD: minimize contrast; dose-adjust anticoagulants/colchicine.\\n\\nFinal plan complete.', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 2494, 'prompt_tokens': 7580, 'total_tokens': 10074, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 512, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 2816}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci2DsyUgQLkDRLeMdf6UJ9o3gYhVl', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, name='treatment_plan', id='run--cf50a0c0-b14f-4e69-b864-42a16232e6e7-0', usage_metadata={'input_tokens': 7580, 'output_tokens': 2494, 'total_tokens': 10074, 'input_token_details': {'audio': 0, 'cache_read': 2816}, 'output_token_details': {'audio': 0, 'reasoning': 512}}), AIMessage(content='Dr. Michael Chen (Emergency Medicine): I’m Dr. Michael Chen. Sharp chest pain that worsens with deep breaths or cough is pleuritic by definition, and in the ED my first job is to separate life-threatening from benign causes within minutes. My immediate move in any age/sex is the triad of ECG + chest X-ray + bedside ultrasound (lungs and heart). That triad, done in parallel with vitals, often tells me if we’re dealing with PE, pneumothorax, pneumonia/effusion, pericarditis/tamponade, or something less ominous.\\n\\nKey questions for you (answer any you can; otherwise, I’ll keep both pathways in play):\\n- Onset: sudden vs gradual? Any recent travel/immobilization, surgery, or trauma?\\n- Associated: shortness of breath, syncope, hemoptysis, fever/chills, productive cough, rash, wheeze?\\n- Risk factors: leg swelling/pain, prior DVT/PE, cancer, pregnancy/postpartum, estrogen/OCPs, smoking/vaping.\\n- Pain character: better leaning forward? reproducible with touch? tearing to the back?\\n- History: asthma/COPD, prior pneumothorax, connective tissue disease, known heart disease.\\n\\nWhile we await that, I’ll outline my ED approach:\\n- Unstable (hypotension, severe hypoxia, altered): rapid ultrasound rules in/out tension pneumothorax or tamponade; manage immediately. If massive PE suspected with shock and RV strain, consider thrombolysis after quick team huddle and exclusion of dissection.\\n- Stable: ECG and high-sensitivity troponin at 0/1 hour; CXR; POCUS lung/cardiac; D-dimer only if indicated by pretest probability (PERC/Wells/YEARS). I avoid reflex CTs.\\n\\nDr. Sofia Alvarez (Cardiology): I’m Dr. Sofia Alvarez. Pleuritic pain can still be cardiac. Two pitfalls I fight daily: missing atypical ACS and mislabeling myopericarditis.\\n- ACS: Don’t dismiss because pain is pleuritic. I want repeat ECGs at 30–60 minutes and a hs-troponin delta using a 0/1-hour algorithm. Regional wall motion abnormality on echo with a non-ischemic ECG still means ischemia until proven otherwise. Cocaine use can cause vasospasm with pleuritic features.\\n- Pericarditis/myopericarditis:\\n  - Clues: pain worse supine, better leaning forward; pericardial friction rub; diffuse concave ST elevation with PR depression; reciprocal PR elevation in aVR. Mild troponin rise suggests myocarditis overlap.\\n  - Echo: quantify effusion; look for tamponade signs (RA/RV diastolic collapse, plethoric IVC).\\n  - Treatment specifics: ibuprofen 600–800 mg three times daily plus colchicine 0.5–0.6 mg twice daily (once daily if <70 kg) for 3 months; gastroprotection. Admit if fever >38°C, large effusion, elevated troponin, immunosuppression, trauma, or anticoagulated. Avoid anticoagulation unless there’s proven VTE.\\n- Aortic dissection: If tearing pain to the back, pulse/BP asymmetry, neuro deficits, or mediastinal widening, I want immediate beta-blockade (esmolol) and CTA aorta; anticoagulation would be dangerous.\\n\\nI will argue for a 2-minute focused cardiac ultrasound before starting empiric anticoagulation when there’s any concern for pericardial disease or dissection.\\n\\nDr. Aisha Rahman (Pulmonology): I’m Dr. Aisha Rahman. Pleuritic pain is pulmonary until proven otherwise—PE, pneumothorax, and pneumonia are my top three.\\n- Pulmonary embolism:\\n  - Use pretest tools first. If suspicion is low and PERC is negative (age <50, HR <100, SpO2 ≥95%, no hemoptysis, no estrogen, no prior VTE, no recent surgery/trauma, no unilateral leg swelling), you need neither D-dimer nor CT.\\n  - Low/intermediate probability: use an age-adjusted D-dimer (age×10 ng/mL FEU if ≥50). Negative rules out PE without imaging.\\n  - High probability or YEARS-positive: go straight to imaging; if imaging is delayed and bedside echo shows no pericardial effusion and there are no dissection signs, start anticoagulation. In pregnancy, use LMWH and favor V/Q scan if CXR is normal.\\n  - Risk stratify confirmed PE: sPESI, RV strain on echo/CT, and troponin/BNP. Massive PE with shock needs thrombolysis or catheter therapy; low-risk PE can go home on a DOAC with close follow-up if bleeding risk is low.\\n- Pneumothorax:\\n  - POCUS: absent lung sliding with barcode sign; lung point is highly specific. Treat tension pneumothorax immediately—don’t wait for imaging.\\n  - Small primary pneumothorax: oxygen and observation with repeat imaging; large/symptomatic or secondary (COPD/older age) needs aspiration or chest tube; consider VATS/pleurodesis if recurrent.\\n- Pneumonia/pleurisy:\\n  - Fever, cough with sputum, pleural rub, focal crackles; CXR confirms consolidation/effusion. Ultrasound helps identify effusion; do thoracentesis if moderate-large effusion or clinical deterioration to rule out empyema. Start antibiotics promptly if septic.\\n\\nDebate\\n- Dr. Alvarez: Elevations in troponin occur in PE. The echo can quickly identify pericardial effusion or regional wall motion abnormality; I don’t want heparin started if I see a large effusion or dissection clues.\\n- Dr. Rahman: Agreed in equivocal cases, but in classic high-probability PE (pleuritic pain, tachycardia, hypoxia, risk factors, clear CXR, no tearing pain/JVD/muffled heart sounds), anticoagulation should not be delayed. A fast POCUS to exclude effusion is reasonable; comprehensive cardiac workups shouldn’t hold treatment.\\n- Dr. Chen: I’ll mediate with a time goal. We do POCUS immediately in triage. If no effusion or dissection signs and PE is likely, we start anticoagulation while arranging CTPA. Simultaneously, we run ECG/hs-troponin to avoid missing ACS or myopericarditis.\\n\\nDecision pathway we jointly endorse (applies to all ages/sexes; adjust for pregnancy/renal disease):\\n1) Immediately for all:\\n- Vitals, continuous monitoring, ECG, CXR, POCUS (lung and focused cardiac), IV access.\\n- Labs: hs-troponin 0/1-hour, CBC/BMP, pregnancy test when applicable, D-dimer only if warranted by pretest.\\n\\n2) Branches based on findings:\\n- Likely PE:\\n  - Use PERC/Wells/YEARS correctly; age-adjusted D-dimer if low/intermediate risk.\\n  - CTPA if positive D-dimer or high probability. V/Q scan in pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n  - If high probability and imaging delay, start anticoagulation after POCUS excludes effusion/dissection.\\n  - Treatment: apixaban 10 mg twice daily for 7 days then 5 mg twice daily, or rivaroxaban 15 mg twice daily for 21 days then 20 mg daily (not in pregnancy or severe renal impairment). Inpatient/tenuous: IV heparin or enoxaparin 1 mg/kg SC q12h. Pregnancy: LMWH only.\\n- Pneumothorax:\\n  - Tension: immediate needle decompression then chest tube.\\n  - Small primary and stable: oxygen, observe 4–6 hours, repeat film; discharge with 24–48 h follow-up if stable.\\n  - Large/symptomatic or secondary: aspiration or pigtail/chest tube; admit; thoracic surgery if recurrent/persistent leak.\\n- Pericarditis/myopericarditis:\\n  - NSAID (ibuprofen 600–800 mg TID) plus colchicine 0.5–0.6 mg BID (daily if <70 kg) for 3 months; PPI if GI risk.\\n  - Admit if fever >38°C, large effusion, elevated troponin, immunosuppressed, on anticoagulation, trauma, or NSAID failure.\\n  - Tamponade: urgent pericardiocentesis.\\n- ACS:\\n  - STEMI: activate cath; aspirin 325 mg chewed, P2Y12 load, anticoagulate, high-intensity statin; nitrates and analgesia as needed.\\n  - NSTEMI/high-risk: guideline-directed therapy and early invasive strategy; echo for regional wall motion abnormalities.\\n- Pneumonia:\\n  - Outpatient (CURB-65 0–1, stable): amoxicillin 1 g TID or doxycycline 100 mg BID; with comorbidities use amox-clav plus doxy/azithro or a respiratory fluoroquinolone. Inpatient: ceftriaxone plus azithromycin or levofloxacin. Ultrasound if effusion; tap if moderate-large.\\n\\nSpecial populations we’ll account for automatically:\\n- Pregnancy/postpartum: higher PE risk; use pregnancy-adapted YEARS; V/Q favored; LMWH; avoid NSAIDs late 3rd trimester and DOACs.\\n- Advanced CKD: minimize contrast; prefer V/Q; adjust anticoagulants/colchicine doses.\\n- Elderly: use age-adjusted D-dimer; atypical pneumonia and ACS presentations; cautious fluids.\\n\\nWhat we still need from you to finalize your branch today:\\n- Age and pregnancy status, vitals (HR/BP/RR/SpO2/temp).\\n- Presence of fever/cough/sputum, leg swelling or pain, hemoptysis, recent flight/surgery/immobilization, estrogen use, cancer.\\n- Pain modifiers (better leaning forward? reproducible to touch? tearing to back?), smoking/vaping, prior pneumothorax, asthma/COPD.\\n\\nOnce you share those, we’ll commit to the imaging choice (CTPA vs V/Q vs CT coronary vs CTA aorta) and start the specific therapy today, including prescriptions or admission level as needed.\\n\\nConsensus bottom line:\\n- The fastest, safest discriminator is ECG + CXR + POCUS within minutes.\\n- Use PERC/Wells/YEARS correctly to steer D-dimer and avoid unnecessary CT.\\n- Treat immediately when probability is high and delay is harmful, after a quick ultrasound screens out conditions where treatment could backfire.\\n\\nThank you!', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 3059, 'prompt_tokens': 9879, 'total_tokens': 12938, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 768, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 5504}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci2FiskeTKQQbkY9TaTJ2sL4DLF0u', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, id='run--0728f35c-5519-47fa-84f1-ca3efc25e384-0', usage_metadata={'input_tokens': 9879, 'output_tokens': 3059, 'total_tokens': 12938, 'input_token_details': {'audio': 0, 'cache_read': 5504}, 'output_token_details': {'audio': 0, 'reasoning': 768}}), AIMessage(content='Final Medical Treatment Plan: Acute Pleuritic Chest Pain\\n\\nPrimary diagnosis and prioritized differential\\n- Immediate life threats to rule out first:\\n  - Pulmonary embolism (PE)\\n  - Pneumothorax (including tension)\\n  - Acute coronary syndrome (ACS) and myopericarditis\\n  - Acute pericarditis ± tamponade\\n  - Aortic dissection\\n  - Pneumonia ± parapneumonic effusion/empyema\\n- After exclusion of above:\\n  - Viral pleurisy\\n  - Costochondritis/musculoskeletal pain\\n  - Early herpes zoster\\n\\nRecommended diagnostic tests with justification\\n- Universal ED bundle (performed in parallel on arrival):\\n  - Continuous monitoring, pulse oximetry, two IV lines.\\n  - 12-lead ECG now; repeat at 30–60 minutes if symptoms persist/change (ACS, pericarditis, right-heart strain).\\n  - High-sensitivity troponin at 0 and 1 hour (0/1-hour algorithm; delta change informs ACS vs non-ACS injury).\\n  - Chest X-ray (rapidly detects pneumothorax, consolidation, pleural effusion, mediastinal widening).\\n  - Point-of-care ultrasound (POCUS):\\n    - Lung: lung sliding (pneumothorax), B-lines vs consolidation, pleural effusion.\\n    - Cardiac: pericardial effusion/tamponade, RV dilation/strain, gross LV function.\\n    - Focused lower-extremity DVT scan if PE suspected.\\n  - Labs: CBC, BMP (guides contrast/anticoagulant dosing), pregnancy test when applicable; lactate if ill; viral PCR (influenza/COVID) in season.\\n- PE-specific testing (use pretest probability to avoid unnecessary imaging):\\n  - Low suspicion: apply PERC; if negative, no D-dimer or imaging.\\n  - Low/intermediate probability: age-adjusted D-dimer (≥50 years: age×10 ng/mL FEU). Negative rules out PE.\\n  - High probability or YEARS-positive: proceed to CT pulmonary angiography (CTPA). If imaging delay and no dissection/tamponade on POCUS, start anticoagulation.\\n  - V/Q scan instead of CTPA in pregnancy, severe contrast allergy, or advanced CKD with normal CXR.\\n- Pneumothorax: POCUS (absent lung sliding/barcode sign), upright CXR if stable; CT only if equivocal or complex.\\n- Pericarditis/myopericarditis: ECG features (diffuse concave ST elevation, PR depression) and positional pain; transthoracic echo to assess effusion/tamponade. CRP can aid diagnosis and tapering.\\n- Aortic dissection: If tearing pain to back, pulse/BP differential, neuro deficits, or widened mediastinum → emergent CTA aorta (beta-blockade before vasodilator).\\n- Pneumonia/pleurisy: CXR to confirm consolidation/effusion; ultrasound if effusion suspected; diagnostic thoracentesis for moderate-large effusions or deterioration. Procalcitonin is adjunctive only.\\n\\nInitial treatment (condition-directed)\\n- General supportive care:\\n  - Oxygen to maintain SpO2 ≥94% (88–92% if chronic hypercapnia).\\n  - Analgesia: acetaminophen/NSAIDs first-line; avoid opioids if possible. Incentive spirometry for atelectasis prevention.\\n- Pulmonary embolism:\\n  - Start anticoagulation if high clinical probability and POCUS excludes dissection/tamponade:\\n    - Stable/outpatient-eligible: apixaban 10 mg twice daily ×7 days, then 5 mg twice daily; or rivaroxaban 15 mg twice daily ×21 days, then 20 mg daily. Avoid DOACs in pregnancy/severe renal impairment.\\n    - Inpatient/tenuous or need rapid reversibility: IV unfractionated heparin infusion; or enoxaparin 1 mg/kg SC q12h (q24h if CrCl <30 mL/min).\\n    - Pregnancy: LMWH (e.g., enoxaparin 1 mg/kg SC q12h).\\n  - Escalation:\\n    - Massive PE (shock/hypotension): systemic thrombolysis or catheter/mechanical thrombectomy; ICU.\\n    - Intermediate-high risk (RV strain + positive biomarkers): admit with telemetry; consider advanced therapy if decompensating.\\n- Pneumothorax:\\n  - Tension: immediate needle decompression, then chest tube.\\n  - Small primary, minimally symptomatic: supplemental oxygen, observation with repeat imaging at 4–6 hours; discharge with 24–48-hour follow-up if stable/reliable.\\n  - Large/symptomatic or secondary (e.g., COPD): needle aspiration or pigtail/chest tube; admit. Thoracic surgery for recurrence/persistent air leak.\\n- ACS:\\n  - STEMI: activate cath lab; aspirin 325 mg chewed, P2Y12 load, parenteral anticoagulation, high-intensity statin; nitrates/analgesia as appropriate.\\n  - NSTEMI/high-risk: guideline-directed medical therapy and early invasive strategy; echocardiography for wall motion.\\n- Pericarditis (no tamponade):\\n  - Ibuprofen 600–800 mg three times daily (or indomethacin 25–50 mg three times daily) until pain-free, then taper over 2–3 weeks guided by symptoms/CRP.\\n  - Colchicine 0.5–0.6 mg twice daily (once daily if <70 kg or intolerance) for 3 months.\\n  - PPI if GI risk. Avoid anticoagulation unless concurrent VTE. Admit if fever >38°C, large effusion, elevated troponin, immunosuppression, trauma, on anticoagulation, or NSAID failure.\\n  - Tamponade: urgent pericardiocentesis.\\n- Pneumonia:\\n  - Outpatient (CURB-65 0–1, stable):\\n    - No comorbidities: amoxicillin 1 g three times daily or doxycycline 100 mg twice daily.\\n    - With comorbidities: amoxicillin-clavulanate plus doxycycline or azithromycin; or respiratory fluoroquinolone monotherapy if needed.\\n  - Inpatient: ceftriaxone plus azithromycin, or levofloxacin. Start antivirals if influenza/COVID positive per protocol.\\n  - Suspected empyema: ultrasound-guided thoracentesis; drain if complicated.\\n- Viral pleurisy/costochondritis:\\n  - NSAIDs/acetaminophen, topical lidocaine patches, heat/graded activity.\\n  - If zoster suspected: valacyclovir 1 g three times daily for 7 days within 72 hours of rash onset.\\n\\nFollow-up and disposition\\n- Discharge criteria: life threats excluded/treated; stable vitals; adequate oxygenation on room air (or baseline); pain controlled; reliable follow-up and clear return precautions.\\n- PE (low-risk, outpatient on DOAC): follow-up within 1 week (primary care/thrombosis). Anticoagulation minimum 3 months; consider extended therapy if unprovoked or persistent risk. Educate on bleeding precautions and drug interactions; consider age-appropriate cancer screening if unprovoked.\\n- Pneumonia: reassess in 48–72 hours; repeat CXR at 6 weeks if age >50, smoker, or persistent symptoms to confirm resolution and exclude malignancy.\\n- Pericarditis: cardiology follow-up in ~1 week; exercise restriction until symptom and CRP normalization; reinforce NSAID taper and colchicine adherence.\\n- Pneumothorax: repeat CXR in 24–48 hours if outpatient; smoking/vaping cessation; thoracic surgery referral for recurrent events.\\n- Musculoskeletal/viral pleurisy: primary care follow-up in 1 week; escalate if worsening.\\n\\nRed flags and escalation scenarios (seek immediate reassessment)\\n- Worsening dyspnea or new hypoxia (SpO2 <92% on room air).\\n- Syncope/presyncope, severe chest pain escalation, or tearing pain to the back.\\n- Hemodynamic instability (SBP <90 mmHg, sustained HR >120 with symptoms).\\n- Hemoptysis or new unilateral leg swelling/pain.\\n- Persistent fever >38.5°C beyond 72 hours of antibiotics or signs of sepsis (confusion, hypotension, oliguria).\\n- Signs of tamponade (worsening dyspnea, hypotension, JVD, muffled heart sounds).\\n- Bleeding on anticoagulation (melena, hematemesis, severe headache, focal neurologic change).\\n\\nSpecial considerations\\n- Pregnancy/postpartum: higher PE risk. Use pregnancy-adapted YEARS; prefer V/Q scan if CXR normal; anticoagulate with LMWH; avoid NSAIDs in late third trimester and DOACs.\\n- Advanced CKD: minimize contrast; prefer V/Q; adjust anticoagulant/colchicine dosing.\\n- Elderly: use age-adjusted D-dimer; anticipate atypical ACS/pneumonia presentations; cautious fluids.\\n\\nFinal plan complete.', additional_kwargs={'refusal': None}, response_metadata={'token_usage': {'completion_tokens': 2898, 'prompt_tokens': 11850, 'total_tokens': 14748, 'completion_tokens_details': {'accepted_prediction_tokens': 0, 'audio_tokens': 0, 'reasoning_tokens': 960, 'rejected_prediction_tokens': 0}, 'prompt_tokens_details': {'audio_tokens': 0, 'cached_tokens': 7552}}, 'model_name': 'gpt-5-2025-08-07', 'system_fingerprint': None, 'id': 'chatcmpl-Ci2HxaMuzhb4o5rwet5N3VDUlnbEk', 'service_tier': 'default', 'finish_reason': 'stop', 'logprobs': None}, name='treatment_plan', id='run--66b3fbbb-4e70-4693-b168-3e5096a7e961-0', usage_metadata={'input_tokens': 11850, 'output_tokens': 2898, 'total_tokens': 14748, 'input_token_details': {'audio': 0, 'cache_read': 7552}, 'output_token_details': {'audio': 0, 'reasoning': 960}})]\n"
     ]
    }
   ],
   "source": [
    "symptom=input(\"Enter symptom\")\n",
    "max_doctors=3\n",
    "doctors=[]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"5\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": symptom}\n",
    "    ],\n",
    "    \"symptom\": symptom,\n",
    "    \"max_doctors\": max_doctors,\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "final_state = None\n",
    "\n",
    "for event in final_graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    final_state = event\n",
    "\n",
    "\n",
    "print(final_state.keys())\n",
    "print(final_state['doctors'])\n",
    "print(final_state['messages'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "905d7878-ecf8-4586-ab3e-411221b8efaf",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eb2df298-0ba0-4c15-8eba-20fa78f77bcf",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8d516829-8a1d-44ef-946c-809fec8c925d",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
